<!DOCTYPE html><html>
<body>
<b>TABLE&#160;2&#160;&#160;</b>&#160;Genes&#160;for&#160;which&#160;selections&#160;exist&#160;in&#160;<i>&#160;E.coli&#160;</i>&#160;and&#160;<i>S.&#160;typhimurium</i><br/>
Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>ackA</i><br/>
&#160; &#160;E,&#160;S<br/>
Fluoroacetate&#160;resistance<br/>
96,&#160;281,&#160;463,&#160;797<br/>
&#160; L<br/>
<i>ada</i><br/>
&#160; &#160;E<br/>
Nitrosoguanidine&#160;resistance<br/>
693<br/>
<i>add</i><br/>
&#160; &#160;E<br/>
Deoxyadenosine&#160;+&#160;hypoxanthine&#160;satisfaction&#160;of&#160;<i>purB</i>&#160;requirement<br/>
370<br/>
&#160; L<br/>
<i>add</i><br/>
&#160; &#160;S<br/>
Deoxyadenosine&#160;(low)&#160;satisfaction&#160;of&#160;<i>purA</i>&#160;requirement<br/>
326<br/>
&#160; L<br/>
<i>adhCE</i><br/>
&#160; &#160;E<br/>
Chloracetaldehyde&#160;resistance<br/>
157<br/>
<hr/>
<a name=26></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>adhCE</i><br/>
&#160; &#160;E<br/>
Chlorethanol&#160;resistance<br/>
157<br/>
<i>adhE</i><br/>
&#160; &#160;E<br/>
Allyl&#160;alcohol&#160;resistance<br/>
476<br/>
&#160; L<br/>
<i>adh</i><br/>
&#160; &#160;E<br/>
Ethanol&#160;as&#160;C&#160;source<br/>
132<br/>
&#160; C<br/>
<i>alaS</i><br/>
&#160; &#160;E<br/>
Thymineless&#160;death&#160;resistance&#160;in&#160;<i>thyA</i><br/>
394<br/>
&#160; S<br/>
<i>alaS</i><br/>
&#160; &#160;E<br/>
Mecillinam&#160;resistance&#160;(beta-lactam&#160;resistance)<br/>
802<br/>
&#160; S<br/>
<i>ampC</i><br/>
&#160; &#160;E<br/>
Ampicillin&#160;resistance<br/>
139,&#160;570<br/>
&#160; D<br/>
<i>ampC</i><br/>
&#160; &#160;E<br/>
Ampicillin&#160;resistance<br/>
210,&#160;212,&#160;362<br/>
&#160; C<br/>
<i>amtAB</i><br/>
&#160; &#160;S<br/>
Aminotriazole&#160;resistance<br/>
828<br/>
<i>apeA</i><br/>
&#160; &#160;E,&#160;S<br/>
<i>N</i>-Acetyl-L-phenylalanine-β-naphthyl&#160;ester&#160;hydrolysis<br/>
421,&#160;516<br/>
&#160; L<br/>
<i>apt</i><br/>
&#160; &#160;E<br/>
6-Methylpurine&#160;resistance<br/>
60<br/>
&#160; L<br/>
<i>apt</i><br/>
&#160; &#160;E<br/>
Adenine&#160;resistance&#160;in&#160;<i>hpt&#160;gpt</i><br/>
462<br/>
<i>apt</i><br/>
&#160; &#160;E<br/>
2,6-Diaminopurine&#160;resistance&#160;in&#160;<i>pnp</i><br/>
470<br/>
&#160; L<br/>
<i>apt</i><br/>
&#160; &#160;E,&#160;S<br/>
2,6-Diaminopurine&#160;resistance<br/>
107,&#160;390<br/>
&#160; L<br/>
<i>araB</i><br/>
&#160; &#160;E<br/>
Ribitol&#160;resistance&#160;from&#160;<i>araC</i>(Con)<br/>
396<br/>
&#160; L<br/>
<i>araC</i><br/>
&#160; &#160;E<br/>
Fucose&#160;resistance&#160;(arabinose&#160;as&#160;C&#160;source)<br/>
67<br/>
&#160; C<br/>
<i>araC</i><br/>
&#160; &#160;E<br/>
Ribitol&#160;resistance&#160;from&#160;<i>araC</i>(Con)<br/>
396<br/>
&#160; L<br/>
<i>arcA</i><br/>
&#160; &#160;E<br/>
Male-specific&#160;phage&#160;resistance;&#160;also&#160;called&#160;<i>fexA</i><br/>
110,&#160;651,&#160;711<br/>
&#160; L<br/>
<i>argA</i><br/>
&#160; &#160;E<br/>
Acetylornithine&#160;+&#160;uracil&#160;satisfaction&#160;of&#160;<i>car</i>&#160;(<i>pyrA</i>)<br/>
153<br/>
&#160; L<br/>
<i>argB</i><br/>
&#160; &#160;E<br/>
<i>N</i>-Acetylhistidine&#160;+&#160;ornithine&#160;satisfaction&#160;of&#160;<i>his</i><br/>
50<br/>
&#160; C<br/>
<i>argB</i><br/>
&#160; &#160;E<br/>
Acetylornithine&#160;+&#160;uracil&#160;satisfaction&#160;of&#160;<i>car</i>&#160;(<i>pyrA</i>)<br/>
153<br/>
&#160; L<br/>
<i>argC</i><br/>
&#160; &#160;E<br/>
<i>N</i>-Acetylhistidine&#160;+&#160;ornithine&#160;satisfaction&#160;of&#160;<i>his</i><br/>
50<br/>
&#160; C<br/>
<i>argC</i><br/>
&#160; &#160;E<br/>
Acetylornithine&#160;+&#160;uracil&#160;satisfaction&#160;of&#160;<i>car</i>&#160;(<i>pyrA</i>)<br/>
153<br/>
&#160; L<br/>
<i>argD</i><br/>
&#160; &#160;E,&#160;S<br/>
Proline-independent&#160;growth&#160;of&#160;∆<i>proAB</i><br/>
62,&#160;403<br/>
&#160; L<br/>
<i>argD</i><br/>
&#160; &#160;E<br/>
Acetylornithine&#160;+&#160;uracil&#160;satisfaction&#160;of&#160;<i>car</i>&#160;(<i>pyrA</i>)<br/>
153<br/>
&#160; L<br/>
<i>argE</i><br/>
&#160; &#160;E<br/>
<i>N</i>-Acetylhistidine&#160;+&#160;ornithine&#160;satisfaction&#160;of&#160;<i>his</i><br/>
50<br/>
&#160; C<br/>
<i>argE</i><br/>
&#160; &#160;E<br/>
Acetylnorvaline&#160;resistance&#160;in&#160;<i>argR</i>(Con)<br/>
402<br/>
&#160; L<br/>
<i>argH</i><br/>
&#160; &#160;E<br/>
<i>N</i>-Acetylhistidine&#160;+&#160;ornithine&#160;satisfaction&#160;of&#160;<i>his</i><br/>
50<br/>
&#160; C<br/>
<i>argP</i><br/>
&#160; &#160;E<br/>
Canavanine&#160;resistance<br/>
483,&#160;655<br/>
&#160; L<br/>
<i>argP</i><br/>
&#160; &#160;E<br/>
Thiosine&#160;resistance<br/>
293,&#160;716<br/>
&#160; L<br/>
<i>argP</i><br/>
&#160; &#160;E<br/>
Canavanine&#160;+&#160;thiouracil&#160;resistance<br/>
605<br/>
&#160; L<br/>
<i>argR</i><br/>
&#160; &#160;E,&#160;S<br/>
Arginine-resistant,&#160;proline-independent&#160;growth&#160;of&#160;∆<i>pro</i><br/>
62,&#160;403<br/>
&#160; C<br/>
<i>argR</i><br/>
&#160; &#160;E<br/>
Acetylhistidine&#160;satisfaction&#160;of&#160;<i>his</i><br/>
49,&#160;50,&#160;403<br/>
&#160; C<br/>
<i>argR</i><br/>
&#160; &#160;E<br/>
Acetylmethionine&#160;satisfaction&#160;of&#160;<i>met</i><br/>
402<br/>
&#160; C<br/>
<i>argR</i><br/>
&#160; &#160;E<br/>
Indospicine&#160;resistance<br/>
454<br/>
&#160; C<br/>
<i>argR</i><br/>
&#160; &#160;E<br/>
Canavanine&#160;resistance<br/>
482,&#160;523<br/>
&#160; C<br/>
<i>argR</i><br/>
&#160; &#160;E<br/>
Glycylglycyl-<i>N</i>-phosphonoacetylornithine&#160;resistance<br/>
604<br/>
&#160; C<br/>
<i>argR</i><br/>
&#160; &#160;E<br/>
Canavanine&#160;+&#160;azauracil&#160;resistance<br/>
605<br/>
&#160; C<br/>
<i>argR</i><br/>
&#160; &#160;E<br/>
Canavanine&#160;+&#160;thiouracil&#160;resistance<br/>
605<br/>
&#160; C<br/>
<i>argR</i><br/>
&#160; &#160;E<br/>
Acetylnorvaline&#160;resistance&#160;in&#160;<i>argR</i>(Con)<br/>
402<br/>
<i>argS</i><br/>
&#160; &#160;E<br/>
Canavanine&#160;resistance<br/>
322<br/>
&#160; S<br/>
<i>argS</i><br/>
&#160; &#160;E<br/>
Mecillinam&#160;resistance&#160;(beta-lactam&#160;resistance)<br/>
802<br/>
&#160; S<br/>
<i>argT</i><br/>
&#160; &#160;S<br/>
Hydrazino&#160;(α)&#160;imidazole&#160;propionic&#160;acid&#160;resistance<br/>
432,&#160;433<br/>
<i>aroA</i><br/>
&#160; &#160;E,&#160;S<br/>
Glyphosate&#160;resistance<br/>
512,&#160;731;&#160;Comai<i>d</i><br/>
&#160; C,&#160;D<br/>
<i>aroF</i><br/>
&#160; &#160;E<br/>
Amino(4)phenylalanine&#160;resistance<br/>
504<br/>
&#160; C<br/>
<i>aroF</i><br/>
&#160; &#160;S<br/>
Fluoro(4)phenylalanine&#160;resistance<br/>
270,&#160;729<br/>
&#160; C<br/>
<i>aroG</i><br/>
&#160; &#160;E,&#160;S<br/>
Methyl(3)anthranilate&#160;resistance<br/>
307<br/>
&#160; FBI,&#160;S<br/>
<i>aroG</i><br/>
&#160; &#160;E<br/>
Thienylalanine&#160;resistance<br/>
215<br/>
&#160; FBI,&#160;S<br/>
<i>aroG</i><br/>
&#160; &#160;E<br/>
Fluorophenylalanine&#160;resistance<br/>
351<br/>
&#160; FBI,&#160;S<br/>
<i>aroH</i><br/>
&#160; &#160;E<br/>
Tryptophan&#160;analog&#160;resistance<br/>
637<br/>
&#160; FBI,&#160;S<br/>
<i>aroP</i><br/>
&#160; &#160;E,&#160;S<br/>
Methyl(5)tryptophan&#160;resistance<br/>
12,&#160;94,&#160;288,&#160;303,<br/>
&#160; L,&#160;C<br/>
393,&#160;437–439<br/>
<i>aroP</i><br/>
&#160; &#160;E,&#160;S<br/>
Fluoro(5)tryptophan&#160;resistance<br/>
12,&#160;94,&#160;288,&#160;303,<br/>
&#160; L<br/>
393,&#160;437–439<br/>
<i>aroP</i><br/>
&#160; &#160;E,&#160;S<br/>
Azaserine&#160;resistance<br/>
12,&#160;94,&#160;288,&#160;303,<br/>
&#160; L<br/>
<hr/>
<a name=27></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
393,&#160;437–439,&#160;836,<br/>837<br/>
<i>aroP</i><br/>
&#160; &#160;E,&#160;S<br/>
Thienylalanine&#160;resistance<br/>
12,&#160;94,&#160;288,&#160;303,<br/>
&#160; L<br/>
393,&#160;437–439<br/>
<i>aroP</i><br/>
&#160; &#160;E,&#160;S<br/>
Fluorophenylalanine&#160;resistance<br/>
12,&#160;94,&#160;288,&#160;303,<br/>
&#160; L<br/>
393,&#160;437–439<br/>
<i>aroP</i><br/>
&#160; &#160;E,&#160;S<br/>
Azaleucine&#160;resistance<br/>
12,&#160;94,&#160;288,&#160;303,<br/>
&#160; L<br/>
393,&#160;437–439<br/>
<i>aroP</i><br/>
&#160; &#160;E,&#160;S<br/>
Methyl(5)tryptophan&#160;+&#160;thienylalanaine&#160;resistance<br/>
12,&#160;94,&#160;288,&#160;303,<br/>
&#160; L<br/>
393,&#160;437–439<br/>
<i>aroT</i><br/>
&#160; &#160;E,&#160;S<br/>
Indole&#160;acrylic&#160;acid&#160;resistance<br/>
769<br/>
&#160; L<br/>
<i>aroT</i><br/>
&#160; &#160;E<br/>
Methyl(4)tryptophan&#160;resistance&#160;in&#160;<i>aroP</i><br/>
594<br/>
&#160; L<br/>
<i>asm</i><br/>
&#160; &#160;S<br/>
Methionine&#160;sulfoxamine&#160;resistance<br/>
188<br/>
<i>atoB</i><br/>
&#160; &#160;S<br/>
Dinitropyrene&#160;resistance<br/>
590<br/>
&#160; L<br/>
<i>atoC</i><br/>
&#160; &#160;E<br/>
Butyrate&#160;as&#160;C&#160;source&#160;in&#160;<i>fadR</i>(Con)<br/>
602<br/>
&#160; C<br/>
<i>atoC</i><br/>
&#160; &#160;E<br/>
Valerate&#160;as&#160;C&#160;source&#160;in&#160;<i>fadR</i>(Con)<br/>
602<br/>
&#160; C<br/>
<i>atoC</i><br/>
&#160; &#160;E<br/>
Penten(4)oate&#160;resistance&#160;in&#160;<i>atoC</i>(Con)<br/>
669<br/>
&#160; L<br/>
<i>atpA–atpE</i><br/>
&#160; &#160;E<br/>
Uncoupler&#160;resistances,&#160;including&#160;DCCD<br/>
225,&#160;226,&#160;229,&#160;355,<br/>
&#160; L<br/>
537<br/>
<i>atpA–atpE</i><br/>
&#160; &#160;E<br/>
Tributyl&#160;tin&#160;resistance<br/>
355<br/>
<i>atpA–atpE</i><br/>
&#160; &#160;E<br/>
CCCP&#160;resistance<br/>
355<br/>
<i>atpA–atpE</i><br/>
&#160; &#160;E<br/>
Pentachlorophenol&#160;resistance<br/>
355<br/>
<i>atpA–atpE</i><br/>
&#160; &#160;E<br/>
Auroventin&#160;resistance<br/>
451,&#160;685,&#160;818<br/>
&#160; L<br/>
<i>atpA–atpE</i><br/>
&#160; &#160;E<br/>
Kanamycin&#160;resistance<br/>
768<br/>
&#160; L<br/>
<i>atpA–atpE</i><br/>
&#160; &#160;E<br/>
Neomycin&#160;resistance<br/>
392<br/>
&#160; L<br/>
<i>atpA–atpE</i><br/>
&#160; &#160;E<br/>
Azide&#160;resistance<br/>
355<br/>
<i>atr</i><br/>
&#160; &#160;S<br/>
Acid&#160;resistance<br/>
233<br/>
<i>azaAB</i><br/>
&#160; &#160;E<br/>
Azaserine&#160;resistance<br/>
836<br/>
<i>azl</i><br/>
&#160; &#160;E<br/>
Azaleucine&#160;resistance<br/>
610<br/>
<i>bglBC</i><br/>
&#160; &#160;E<br/>
Arbutin&#160;as&#160;C&#160;source<br/>
523,&#160;616,&#160;640<br/>
<i>bglBC</i><br/>
&#160; &#160;E<br/>
Salicin&#160;as&#160;C&#160;source<br/>
523,&#160;616,&#160;640<br/>
<i>bglT</i><br/>
&#160; &#160;E<br/>
Methyl(β)glucoside&#160;as&#160;C&#160;source<br/>
686<br/>
&#160; C<br/>
<i>bio</i>&#160;operon<br/>
&#160; &#160;E<br/>
Dehydrobiotin&#160;resistance<br/>
206<br/>
<i>bioP</i><br/>
&#160; &#160;E<br/>
Dehydrobiotin&#160;resistance<br/>
206<br/>
&#160; L<br/>
<i>birA</i><br/>
&#160; &#160;E<br/>
Dehydrobiotin&#160;resistance<br/>
206,&#160;597<br/>
<i>brnQ</i><br/>
&#160; &#160;E<br/>
Methyl(<i>o</i>)threonine&#160;resistance<br/>
278<br/>
&#160; L<br/>
<i>brnQ</i><br/>
&#160; &#160;E<br/>
Valine&#160;resistance<br/>
277<br/>
&#160; L<br/>
<i>btuB</i><br/>
&#160; &#160;E<br/>
Colicin&#160;E3&#160;tolerance<br/>
46,&#160;47,&#160;109,&#160;284,<br/>388,&#160;620<br/>
<i>btuB</i><br/>
&#160; &#160;E,&#160;S<br/>
Bf23&#160;phage&#160;resistance<br/>
46,&#160;47,&#160;109,&#160;284,<br/>388,&#160;528,&#160;620<br/>
<i>bymA</i><br/>
&#160; &#160;E<br/>
Maltose&#160;utilization&#160;in&#160;<i>malT</i><br/>
327<br/>
<i>cbt</i><br/>
&#160; &#160;E<br/>
Chloroacetate(β)&#160;resistance<br/>
68<br/>
&#160; L<br/>
<i>cbt</i><br/>
&#160; &#160;E<br/>
Colicin&#160;B&#160;tolerance<br/>
623<br/>
&#160; L<br/>
<i>cbt</i><br/>
&#160; &#160;E<br/>
Colicin&#160;D&#160;tolerance<br/>
623<br/>
&#160; L<br/>
<i>cdd</i><br/>
&#160; &#160;E<br/>
Aza(5)-2′-deoxycytidine&#160;resistance<br/>
196<br/>
&#160; L<br/>
<i>cdd</i><br/>
&#160; &#160;E,&#160;S<br/>
Fluoro(5)deoxycytidine&#160;resistance<br/>
53,&#160;579<br/>
&#160; L<br/>
<i>celABCDF</i><br/>
&#160; &#160;E<br/>
Cellobiose&#160;as&#160;C&#160;source<br/>
426<br/>
<i>cet</i><br/>
&#160; &#160;E<br/>
Colicin&#160;E2&#160;tolerance<br/>
201<br/>
<i>che</i><br/>
&#160; &#160;S<br/>
Migration&#160;in&#160;a&#160;chemotaxis&#160;gradient<br/>
34<br/>
<i>chlABDEG</i><br/>
&#160; &#160;E,&#160;S<br/>
Chlorate&#160;resistance<br/>
2,&#160;121,&#160;122,&#160;228,<br/>
&#160; L<br/>
266,&#160;523,&#160;743,&#160;744<br/>
<i>chlABDE</i><br/>
&#160; &#160;E<br/>
Lactate&#160;+&#160;fumarate&#160;as&#160;anaerobic&#160;energy&#160;source<br/>
436<br/>
&#160; L<br/>
<i>chlC</i><br/>
&#160; &#160;S<br/>
Chlorate&#160;resistance<br/>
45<br/>
&#160; L<br/>
<i>chlE</i><br/>
&#160; &#160;E<br/>
Lactate&#160;+&#160;nitrate&#160;as&#160;anaerobic&#160;energy&#160;source<br/>
799<br/>
<i>chlE</i><br/>
&#160; &#160;E<br/>
Biotin&#160;sulfoxide&#160;utilization&#160;in&#160;<i>chl&#160;bio</i><br/>
180<br/>
<i>cirA</i><br/>
&#160; &#160;E<br/>
Colicin&#160;I&#160;resistance<br/>
77,&#160;93,&#160;620<br/>
&#160; L<br/>
<i>cirA</i><br/>
&#160; &#160;E<br/>
Siderophore–beta-lactam&#160;conjugate&#160;resistance<br/>
93<br/>
&#160; L<br/>
<hr/>
<a name=28></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>cit</i><br/>
&#160; &#160;E<br/>
Citrate&#160;as&#160;C&#160;source<br/>
290<br/>
<i>cls</i><br/>
&#160; &#160;E<br/>
Dihydroxy(3,4)butyl-1-phosphonate&#160;resistance<br/>
345<br/>
&#160; L<br/>
<i>cmlA</i><br/>
&#160; &#160;E<br/>
Chloramphenicol&#160;resistance<br/>
48<br/>
<i>cmlA</i><br/>
&#160; &#160;E<br/>
Tetracycline&#160;resistance<br/>
523,&#160;638<br/>
<i>coaA</i><br/>
&#160; &#160;E<br/>
Coenzyme&#160;A&#160;feedback&#160;resistance<br/>
789,&#160;790<br/>
&#160; FBI,&#160;S<br/>
<i>codA</i>(<i>cod</i>)<br/>
&#160; &#160;E,&#160;S<br/>
Fluoro(5)cytosine&#160;resistance<br/>
4,&#160;54<br/>
&#160; L<br/>
<i>corABCD</i><br/>
&#160; &#160;E,&#160;S<br/>
Cobalt&#160;resistance<br/>
262,&#160;600,&#160;817<br/>
<i>corABCD</i><br/>
&#160; &#160;E<br/>
Manganese&#160;resistance<br/>
600<br/>
<i>corABCD</i><br/>
&#160; &#160;E<br/>
Nickel&#160;resistance<br/>
817<br/>
<i>cpd</i><br/>
&#160; &#160;S<br/>
Succinate&#160;as&#160;improved&#160;C&#160;source<br/>
8,&#160;530<br/>
&#160; L<br/>
<i>cpd</i><br/>
&#160; &#160;S<br/>
Citrate&#160;as&#160;C&#160;source&#160;in&#160;presence&#160;of&#160;low&#160;cAMP<br/>
8<br/>
&#160; L<br/>
<i>cpdB</i><br/>
&#160; &#160;E<br/>
Fluorouracil(5)&#160;and&#160;3′-AMP&#160;resistance<br/>
51<br/>
&#160; L<br/>
<i>cpxA</i><br/>
&#160; &#160;E<br/>
Amikacin&#160;resistance<br/>
629<br/>
<i>cpxA</i><br/>
&#160; &#160;E<br/>
Colicin&#160;A&#160;tolerance<br/>
629<br/>
<i>cpxA</i><br/>
&#160; &#160;E<br/>
Kanamycin&#160;resistance<br/>
768<br/>
<i>cpxA</i><br/>
&#160; &#160;E<br/>
Q&#160;phage&#160;resistance<br/>
508,&#160;711<br/>
<i>cpxA</i><br/>
&#160; &#160;E<br/>
Serine&#160;(L)&#160;as&#160;C&#160;source<br/>
567<br/>
<i>crg</i><br/>
&#160; &#160;E<br/>
Cold-resistant&#160;growth<br/>
398<br/>
<i>crp</i><br/>
&#160; &#160;S<br/>
Fosfomycin&#160;resistance<br/>
10<br/>
&#160; L<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
Serine&#160;(L)&#160;resistance&#160;in&#160;<i>relA</i><br/>
167<br/>
&#160; L<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;+&#160;nalidixic&#160;acid&#160;resistance<br/>
429<br/>
&#160; L<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
Streptomycin&#160;+&#160;cAMP&#160;resistance<br/>
31<br/>
&#160; L<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;resistance&#160;with&#160;maltose&#160;and&#160;arabinose&#160;as<br/>
92,&#160;766<br/>
&#160; L<br/>
C&#160;sources<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
cAMP&#160;+&#160;glucose&#160;6-phosphate&#160;resistance<br/>
1a<br/>
&#160; L<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
cAMP&#160;+&#160;glucose&#160;6-phosphate&#160;+&#160;D-xylose&#160;+&#160;L-arabinose<br/>
1a<br/>
&#160; L<br/>
resistance<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
Fluorouracil(5)&#160;+&#160;5′-AMP&#160;+&#160;3′-AMP&#160;resistance<br/>
52<br/>
&#160; L<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
Osmotolerance<br/>
282<br/>
&#160; L<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
Beta-lactam&#160;resistance<br/>
362<br/>
&#160; L<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
Mecillinam&#160;resistance<br/>
25,&#160;168,&#160;857<br/>
&#160; L<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
UV light&#160;resistance<br/>
627<br/>
&#160; L<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
Rifampin&#160;resistance<br/>
413<br/>
&#160; L<br/>
<i>crp</i><br/>
&#160; &#160;E<br/>
T6&#160;phage&#160;resistance<br/>
6<br/>
&#160; L<br/>
<i>crr</i><br/>
&#160; &#160;E<br/>
Thio(5)glucose&#160;resistance<br/>
419<br/>
&#160; L<br/>
<i>crr</i><br/>
&#160; &#160;S<br/>
Methylglucoside(α)-resistant&#160;utilization&#160;of&#160;glycerol&#160;in<br/>
563<br/>
&#160; L<br/>
<i>ptsHI</i><br/>
<i>cxm</i><br/>
&#160; &#160;E<br/>
Xylose&#160;(D)&#160;+&#160;cAMP&#160;resistance<br/>
1a<br/>
&#160; L<br/>
<i>cyaA</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;resistance&#160;with&#160;maltose&#160;and&#160;arabinose&#160;as<br/>
92<br/>
&#160; L<br/>
C&#160;sources<br/>
<i>cyaA</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;+&#160;nalidixic&#160;acid&#160;resistance<br/>
429<br/>
&#160; L<br/>
<i>cyaA</i><br/>
&#160; &#160;E<br/>
Serine&#160;(L)&#160;resistance&#160;in&#160;<i>relA</i><br/>
167<br/>
&#160; L<br/>
<i>cyaA</i><br/>
&#160; &#160;S<br/>
Fosfomycin&#160;resistance<br/>
10<br/>
&#160; L<br/>
<i>cyaA</i><br/>
&#160; &#160;E<br/>
Osmotolerance<br/>
282<br/>
&#160; L<br/>
<i>cyaA</i><br/>
&#160; &#160;E<br/>
Beta-lactam&#160;resistance<br/>
362<br/>
&#160; L<br/>
<i>cyaA</i><br/>
&#160; &#160;E<br/>
Mecillinam&#160;resistance<br/>
25,&#160;168,&#160;857<br/>
&#160; L<br/>
<i>cyaA</i><br/>
&#160; &#160;E<br/>
UV light&#160;resistance<br/>
627<br/>
&#160; L<br/>
<i>cyaA</i><br/>
&#160; &#160;E<br/>
Rifampin&#160;resistance<br/>
413<br/>
&#160; L<br/>
<i>cyaA</i><br/>
&#160; &#160;E<br/>
T6&#160;phage&#160;resistance<br/>
6<br/>
&#160; L<br/>
<i>cycA</i><br/>
&#160; &#160;E<br/>
Cycloserine&#160;(D)&#160;resistance<br/>
150,&#160;646,&#160;813<br/>
&#160; L<br/>
<i>cycA</i><br/>
&#160; &#160;E<br/>
Serine&#160;(D)&#160;resistance<br/>
689<br/>
&#160; L<br/>
<i>cysA</i><br/>
&#160; &#160;S<br/>
Chromate&#160;resistance<br/>
581<br/>
&#160; L<br/>
<i>cysA</i><br/>
&#160; &#160;E<br/>
Selenate&#160;resistance<br/>
728<br/>
&#160; L<br/>
<i>cysA</i><br/>
&#160; &#160;S<br/>
Azaserine&#160;resistance<br/>
340,&#160;689<br/>
&#160; L<br/>
<i>cysB</i><br/>
&#160; &#160;S<br/>
Chromate&#160;resistance<br/>
340<br/>
&#160; L<br/>
<i>cysB</i><br/>
&#160; &#160;S<br/>
Azide&#160;resistance<br/>
227<br/>
&#160; C<br/>
<i>cysB</i><br/>
&#160; &#160;S<br/>
Selenate&#160;resistance<br/>
339<br/>
&#160; L<br/>
<i>cysB</i><br/>
&#160; &#160;E<br/>
Novobiocin&#160;resistance<br/>
631<br/>
&#160; L<br/>
<i>cysB</i><br/>
&#160; &#160;S<br/>
Triazole&#160;resistance<br/>
227<br/>
&#160; C<br/>
<i>cysB</i><br/>
&#160; &#160;S<br/>
Azaserine&#160;resistance<br/>
340<br/>
&#160; L<br/>
<hr/>
<a name=29></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>cysC</i><br/>
&#160; &#160;S<br/>
Azaserine&#160;resistance<br/>
340<br/>
&#160; L<br/>
<i>cysC</i><br/>
&#160; &#160;S<br/>
Chromate&#160;resistance<br/>
581<br/>
&#160; L<br/>
<i>cysD</i><br/>
&#160; &#160;S<br/>
Azaserine&#160;resistance<br/>
340<br/>
&#160; L<br/>
<i>cysD</i><br/>
&#160; &#160;S<br/>
Chromate&#160;resistance<br/>
581<br/>
&#160; L<br/>
<i>cysE</i><br/>
&#160; &#160;S<br/>
Triazole&#160;resistance&#160;in&#160;<i>cysM</i><br/>
717,&#160;825<br/>
&#160; C<br/>
<i>cysE</i><br/>
&#160; &#160;S<br/>
Triazole&#160;resistance<br/>
341<br/>
&#160; C<br/>
<i>cysE</i><br/>
&#160; &#160;E<br/>
Novobiocin&#160;resistance<br/>
631<br/>
&#160; L<br/>
<i>cysG</i><br/>
&#160; &#160;S<br/>
Azaserine&#160;resistance<br/>
340<br/>
&#160; L<br/>
<i>cysH</i><br/>
&#160; &#160;S<br/>
Azaserine&#160;resistance<br/>
340<br/>
&#160; L<br/>
<i>cysH</i><br/>
&#160; &#160;S<br/>
Chromate&#160;resistance<br/>
581<br/>
&#160; L<br/>
<i>cysI</i><br/>
&#160; &#160;S<br/>
Azaserine&#160;resistance<br/>
340<br/>
&#160; L<br/>
<i>cysI</i><br/>
&#160; &#160;S<br/>
Chromate&#160;resistance<br/>
581<br/>
&#160; L<br/>
<i>cysJ</i><br/>
&#160; &#160;S<br/>
Azaserine&#160;resistance<br/>
340<br/>
&#160; L<br/>
<i>cysJ</i><br/>
&#160; &#160;S<br/>
Chromate&#160;resistance<br/>
581<br/>
&#160; L<br/>
<i>cysK</i><br/>
&#160; &#160;S,&#160;E<br/>
Azaserine&#160;resistance<br/>
340,&#160;827<br/>
&#160; L<br/>
<i>cysK</i><br/>
&#160; &#160;S<br/>
Azide&#160;resistance<br/>
147,&#160;227<br/>
&#160; L<br/>
<i>cysK</i><br/>
&#160; &#160;E<br/>
Selenate&#160;resistance<br/>
230<br/>
&#160; L<br/>
<i>cysK</i><br/>
&#160; &#160;E,&#160;S<br/>
Triazole&#160;resistance<br/>
147,&#160;227,&#160;826,&#160;827<br/>
&#160; L,&#160;C<br/>
<i>cysK</i><br/>
&#160; &#160;E<br/>
Selenite&#160;resistance<br/>
230<br/>
&#160; L<br/>
<i>cysL</i><br/>
&#160; &#160;S<br/>
Selenate&#160;resistance<br/>
673,&#160;674<br/>
<i>cysL</i><br/>
&#160; &#160;S<br/>
Chromate&#160;+&#160;selenate&#160;resistance<br/>
338<br/>
<i>cysM</i><br/>
&#160; &#160;S<br/>
Azaserine&#160;resistance<br/>
340<br/>
&#160; L<br/>
<i>cytR</i><br/>
&#160; &#160;E<br/>
Uridine&#160;as&#160;C&#160;source,&#160;improved&#160;utilization<br/>
546<br/>
<i>dadA</i><br/>
&#160; &#160;E,&#160;S<br/>
Chloro(β)-D-alanine&#160;resistance<br/>
832<br/>
&#160; L<br/>
<i>dadA</i><br/>
&#160; &#160;E,&#160;S<br/>
D-Amino&#160;acid&#160;satisfaction&#160;of&#160;amino&#160;acid&#160;auxotrophy<br/>
428,&#160;831<br/>
&#160; C<br/>
<i>dcm</i><br/>
&#160; &#160;E<br/>
Aza(5)cytidine&#160;resistance<br/>
247<br/>
&#160; L<br/>
<i>dct</i><br/>
&#160; &#160;E<br/>
Fluoro(3)malate&#160;resistance<br/>
401<br/>
&#160; L<br/>
<i>dct</i><br/>
&#160; &#160;E<br/>
Tartrate&#160;resistance<br/>
687<br/>
&#160; L<br/>
<i>dct</i><br/>
&#160; &#160;S<br/>
Malate&#160;(L)&#160;as&#160;improved&#160;C&#160;source<br/>
745<br/>
&#160; D<br/>
<i>deoA</i><br/>
&#160; &#160;E<br/>
Deoxyadenosine&#160;+&#160;fluorouracil&#160;resistance&#160;in&#160;<i>upp</i><br/>
3<br/>
&#160; L<br/>
<i>deoA</i><br/>
&#160; &#160;E<br/>
Thymidine&#160;resistance&#160;in&#160;<i>deoC</i><br/>
3<br/>
<i>deoB</i><br/>
&#160; &#160;E<br/>
Thymidine&#160;resistance&#160;in&#160;<i>deoC</i><br/>
3,&#160;651<br/>
&#160; L<br/>
<i>deoB</i><br/>
&#160; &#160;E,&#160;S<br/>
Thymineless&#160;death&#160;prevention&#160;by&#160;low&#160;thymine&#160;levels&#160;in<br/>
71,&#160;471<br/>
<i>thyA</i><br/>
<i>deoC</i><br/>
&#160; &#160;E<br/>
Thymineless&#160;death&#160;prevention&#160;by&#160;low&#160;thymine&#160;levels&#160;in<br/>
325,&#160;471,&#160;651<br/>
&#160; L<br/>
<i>thyA</i><br/>
<i>deoD</i><br/>
&#160; &#160;E<br/>
Deoxy(2)adenosine&#160;resistance&#160;in&#160;<i>deoC</i><br/>
651<br/>
&#160; L<br/>
<i>deoD</i><br/>
&#160; &#160;E<br/>
Deoxyadenosine&#160;+&#160;fluorouracil&#160;resistance&#160;in&#160;<i>upp</i><br/>
3<br/>
&#160; L<br/>
<i>deoR</i><br/>
&#160; &#160;E<br/>
Inosine&#160;as&#160;improved&#160;C&#160;source<br/>
546<br/>
&#160; C<br/>
<i>deoR</i><br/>
&#160; &#160;S<br/>
Diamino(2,6)purine&#160;satisfaction&#160;of&#160;purine&#160;auxotrophy<br/>
251<br/>
<i>deoR</i><br/>
&#160; &#160;S<br/>
Uridine&#160;resistance&#160;in&#160;<i>thyA&#160;deoB</i><br/>
71<br/>
<i>dgd</i><br/>
&#160; &#160;E<br/>
Arabitol&#160;(D)&#160;as&#160;C&#160;source&#160;in&#160;<i>fuc</i><br/>
849<br/>
<i>dgoR</i><br/>
&#160; &#160;E<br/>
Keto(2)-3-deoxygalactonate&#160;as&#160;C&#160;source<br/>
144<br/>
&#160; C<br/>
<i>dgsA</i><br/>
&#160; &#160;E<br/>
Glucosamine&#160;as&#160;anaerobic&#160;C&#160;source&#160;in&#160;<i>ptsG</i><br/>
652<br/>
&#160; L<br/>
<i>dhuA</i><br/>
&#160; &#160;E,&#160;S<br/>
Histidine&#160;(D)&#160;satisfaction&#160;of&#160;<i>his</i>&#160;auxotrophs<br/>
422,&#160;428,&#160;546<br/>
<i>dhuA</i><br/>
&#160; &#160;S<br/>
Azaserine&#160;+&#160;tryptophan&#160;resistance<br/>
432<br/>
<i>dld</i><br/>
&#160; &#160;E<br/>
Vinylglycolate&#160;resistance<br/>
696<br/>
&#160; L<br/>
<i>dml</i><br/>
&#160; &#160;S<br/>
Malate&#160;(D)&#160;as&#160;C&#160;source<br/>
737<br/>
<i>dnaB</i><br/>
&#160; &#160;E<br/>
Lambdoid&#160;phage&#160;mixture&#160;coinfection&#160;resistance<br/>
259<br/>
<i>dnaB</i><br/>
&#160; &#160;E<br/>
Phenethyl&#160;alcohol&#160;resistance<br/>
494<br/>
<i>dnaE</i><br/>
&#160; &#160;E<br/>
Acriflavin&#160;(acridine)&#160;resistance<br/>
553–555<br/>
<hr/>
<a name=30></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>dnaE</i><br/>
&#160; &#160;E<br/>
Globomycin&#160;resistance<br/>
668<br/>
&#160; S<br/>
<i>dnaJ</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;induction,&#160;resistance&#160;to<br/>
667<br/>
&#160; S<br/>
<i>dnaJ</i><br/>
&#160; &#160;E<br/>
Lambdoid&#160;phage&#160;mixture&#160;coinfection&#160;resistance<br/>
257,&#160;259<br/>
&#160; S<br/>
<i>dnaJ</i><br/>
&#160; &#160;E<br/>
P2&#160;phage&#160;+&#160;lambda&#160;phage&#160;coinfection&#160;resistance<br/>
753<br/>
&#160; S<br/>
<i>dnaK</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;induction,&#160;resistance&#160;to<br/>
667<br/>
&#160; S<br/>
<i>dnaK</i><br/>
&#160; &#160;E<br/>
Lambdoid&#160;phage&#160;mixture&#160;coinfection&#160;resistance<br/>
257,&#160;259<br/>
&#160; S<br/>
<i>dnaK</i><br/>
&#160; &#160;E<br/>
P2&#160;phage&#160;+&#160;lambda&#160;phage&#160;coninfection&#160;resistance<br/>
753<br/>
&#160; S<br/>
<i>dnaP</i><br/>
&#160; &#160;E<br/>
Phenethyl&#160;alcohol&#160;resistance<br/>
809<br/>
<i>dor</i><br/>
&#160; &#160;S<br/>
Drug-resistant&#160;gene&#160;maintenance<br/>
814<br/>
<i>dppA</i><br/>
&#160; &#160;E,&#160;S<br/>
Bacilysin&#160;resistance<br/>
1<br/>
&#160; L<br/>
<i>dppA</i><br/>
&#160; &#160;E,&#160;S<br/>
Bialaphos&#160;resistance<br/>
1<br/>
&#160; L<br/>
<i>dppA</i><br/>
&#160; &#160;E,&#160;S<br/>
Valine-containing&#160;dipeptide&#160;resistance<br/>
1<br/>
&#160; L<br/>
<i>dppA</i><br/>
&#160; &#160;E<br/>
Lysyl-2-aminoxypropionate&#160;resistance<br/>
603<br/>
&#160; L<br/>
<i>dppA</i><br/>
&#160; &#160;E<br/>
Glycylleucine&#160;resistance<br/>
269<br/>
&#160; L<br/>
<i>dppA</i><br/>
&#160; &#160;E<br/>
Phenylalanylleucine&#160;resistance<br/>
269<br/>
&#160; L<br/>
<i>dppA</i><br/>
&#160; &#160;E<br/>
Glycylvaline&#160;resistance&#160;in&#160;<i>opp</i><br/>
178<br/>
&#160; L<br/>
<i>dsdA</i><br/>
&#160; &#160;E<br/>
Sucrose&#160;as&#160;C&#160;source<br/>
5<br/>
&#160; L<br/>
<i>dsdC</i><br/>
&#160; &#160;E<br/>
Sucrose&#160;as&#160;C&#160;source<br/>
5<br/>
<i>ebgA</i><br/>
&#160; &#160;E<br/>
Lactose&#160;utilization&#160;in&#160;∆<i>lacZ</i><br/>
118<br/>
&#160; Q<br/>
<i>ecfB</i><br/>
&#160; &#160;E<br/>
Serine&#160;(L)&#160;as&#160;C&#160;source<br/>
567,&#160;768<br/>
<i>ecfB</i><br/>
&#160; &#160;E<br/>
Kanamycin&#160;resistance<br/>
567,&#160;768<br/>
<i>ecfB</i><br/>
&#160; &#160;E<br/>
Neomycin&#160;resistance<br/>
608<br/>
<i>ecfB</i><br/>
&#160; &#160;E<br/>
Colicin&#160;K&#160;resistance<br/>
608<br/>
<i>edd</i><br/>
&#160; &#160;E<br/>
Gluconate&#160;as&#160;C&#160;source&#160;in&#160;<i>eda</i><br/>
239,&#160;240<br/>
&#160; L<br/>
<i>emrB</i><br/>
&#160; &#160;E<br/>
CCCP&#160;resistance&#160;due&#160;to&#160;gene&#160;dosage<br/>
472<br/>
&#160; D<br/>
<i>emrB</i><br/>
&#160; &#160;E<br/>
Nalidixic&#160;acid&#160;resistance&#160;due&#160;to&#160;gene&#160;dosage<br/>
472<br/>
&#160; D<br/>
<i>emrB</i><br/>
&#160; &#160;E<br/>
Thiolactomycin&#160;resistance&#160;due&#160;to&#160;gene&#160;dosage<br/>
250<br/>
&#160; D<br/>
<i>emrB</i><br/>
&#160; &#160;E<br/>
Thiolactomycin&#160;resistance<br/>
250<br/>
<i>envB</i><br/>
&#160; &#160;E,&#160;S<br/>
Mecillinam&#160;resistance<br/>
359,&#160;587<br/>
<i>envB</i><br/>
&#160; &#160;E<br/>
UV light&#160;resistance<br/>
24<br/>
<i>envM</i><br/>
&#160; &#160;E,&#160;S<br/>
Diazoborine&#160;resistance<br/>
63<br/>
&#160; S<br/>
<i>envZ</i><br/>
&#160; &#160;E<br/>
Ampicillin&#160;resistance<br/>
362,&#160;363<br/>
<i>envZ</i><br/>
&#160; &#160;E<br/>
Colicin&#160;L&#160;tolerance<br/>
812<br/>
<i>envZ</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;resistance<br/>
812<br/>
<i>envZ</i><br/>
&#160; &#160;E<br/>
Me1&#160;phage&#160;resistance<br/>
801<br/>
<i>envZ</i><br/>
&#160; &#160;E<br/>
TPI&#160;phage&#160;resistance<br/>
812<br/>
<i>envZ</i><br/>
&#160; &#160;E<br/>
TuIa&#160;phage&#160;resistance<br/>
801<br/>
<i>envZ</i><br/>
&#160; &#160;E<br/>
Freeze-thaw&#160;resistance<br/>
112<br/>
<i>envZ</i><br/>
&#160; &#160;E<br/>
Colicin&#160;(multiple)&#160;resistance<br/>
626<br/>
<i>eryC</i><br/>
&#160; &#160;E<br/>
Erythromycin&#160;resistance<br/>
599<br/>
<i>eryD</i><br/>
&#160; &#160;E<br/>
Erythromycin&#160;resistance<br/>
830<br/>
<i>exbB</i><br/>
&#160; &#160;E<br/>
Albomycin&#160;resistance<br/>
205<br/>
<i>exbB</i><br/>
&#160; &#160;E<br/>
Colicin&#160;I&#160;resistance<br/>
283,&#160;624<br/>
<i>exbB</i><br/>
&#160; &#160;E<br/>
Colicin&#160;(other)&#160;resistance<br/>
283,&#160;624<br/>
<i>exbC</i><br/>
&#160; &#160;E<br/>
Colicin&#160;B&#160;resistance<br/>
624<br/>
<i>exbC</i><br/>
&#160; &#160;E<br/>
Colicin&#160;I&#160;resistance<br/>
283,&#160;624<br/>
<i>exbC</i><br/>
&#160; &#160;E<br/>
Colicin&#160;(other)&#160;resistance<br/>
283,&#160;624<br/>
<i>exuR</i><br/>
&#160; &#160;E<br/>
Aldohexuronate&#160;resistance&#160;in&#160;<i>eda</i><br/>
612<br/>
<i>exuR</i><br/>
&#160; &#160;E<br/>
Hexuronate&#160;as&#160;C&#160;course&#160;in&#160;noninducible&#160;<i>exuR&#160;eda</i><br/>
612<br/>
&#160; C<br/>
<i>exuT</i><br/>
&#160; &#160;E<br/>
Aldohexuronate&#160;resistance&#160;in&#160;<i>eda</i><br/>
612<br/>
&#160; L<br/>
<i>fadB</i><br/>
&#160; &#160;E<br/>
Thiolactomycin&#160;resistance&#160;(due&#160;to&#160;gene&#160;dosage)<br/>
778<br/>
&#160; D<br/>
<i>fadL</i><br/>
&#160; &#160;E<br/>
T2&#160;phage&#160;resistance&#160;in&#160;<i>ompF</i>+&#160;or&#160;<i>ompF</i><br/>
70,&#160;534<br/>
&#160; L<br/>
<i>fadR</i><br/>
&#160; &#160;E<br/>
Decanoate&#160;as&#160;C&#160;source<br/>
713<br/>
&#160; L<br/>
<i>fba</i><br/>
&#160; &#160;E<br/>
Streptozotocin&#160;resistance<br/>
456<br/>
&#160; L<br/>
<i>fepABCDG</i><br/>
&#160; &#160;E<br/>
Colicin&#160;B&#160;resistance<br/>
623,&#160;624<br/>
&#160; L<br/>
<i>fepABDCG</i><br/>
&#160; &#160;E<br/>
Colicin&#160;D&#160;resistance<br/>
623<br/>
&#160; L<br/>
<hr/>
<a name=31></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>fhuA</i><br/>
&#160; &#160;E,&#160;S<br/>
Albomycin&#160;resistance<br/>
87,&#160;387,&#160;388,&#160;478,<br/>
&#160; S<br/>
479<br/>
<i>fhuA</i><br/>
&#160; &#160;S<br/>
ES18&#160;phage&#160;resistance<br/>
87,&#160;478,&#160;479<br/>
&#160; S<br/>
<i>fhuA</i><br/>
&#160; &#160;E<br/>
T1&#160;phage&#160;resistance<br/>
93,&#160;409;&#160;Lin&#160;et&#160;al.<i>e</i><br/>
&#160; S,&#160;L<br/>
<i>fhuA</i><br/>
&#160; &#160;E<br/>
T5&#160;phage&#160;resistance<br/>
93,&#160;151,&#160;387;&#160;Lin<br/>
&#160; L<br/>
et&#160;al.<i>e</i><br/>
<i>fhuA</i><br/>
&#160; &#160;E<br/>
Φ80&#160;phage&#160;resistance<br/>
151,&#160;387,&#160;409;&#160;Lin<br/>
&#160; L,&#160;S<br/>
et&#160;al.<i>e</i><br/>
<i>fhuA</i><br/>
&#160; &#160;E<br/>
Colicin&#160;M&#160;resistance<br/>
151,&#160;387,&#160;409<br/>
&#160; L,&#160;S<br/>
<i>fhuA</i><br/>
&#160; &#160;E<br/>
Beta-lactam&#160;conjugate&#160;resistance<br/>
93<br/>
&#160; L<br/>
<i>fhuB</i><br/>
&#160; &#160;E<br/>
Albomycin&#160;resistance<br/>
618<br/>
&#160; L<br/>
<i>fliC</i><br/>
&#160; &#160;E,&#160;S<br/>
Chi&#160;phage&#160;resistance<br/>
347,&#160;349,&#160;416,&#160;417,<br/>513,&#160;710<br/>
<i>fliC</i><br/>
&#160; &#160;S<br/>
Prolonged&#160;static&#160;cultivation<br/>
249<br/>
<i>flrB</i><br/>
&#160; &#160;S<br/>
Trifluoroleucine&#160;resistance<br/>
115,&#160;117<br/>
<i>folA</i><br/>
&#160; &#160;E<br/>
Sulfonamide&#160;resistance<br/>
607,&#160;697<br/>
&#160; S,&#160;D<br/>
<i>folA</i><br/>
&#160; &#160;S<br/>
Trimethoprim&#160;resistance<br/>
405,&#160;654,&#160;718,&#160;719<br/>
&#160; S,&#160;D<br/>
<i>folP</i><br/>
&#160; &#160;E<br/>
Sulfonamide&#160;resistance<br/>
756<br/>
&#160; S<br/>
<i>fruA</i><br/>
&#160; &#160;E<br/>
Deoxy(2)glucose-independent&#160;fructose&#160;utilization<br/>
11<br/>
<i>fruA</i><br/>
&#160; &#160;E<br/>
Xylitol&#160;resistance<br/>
614,&#160;639<br/>
&#160; L<br/>
<i>fruA</i><br/>
&#160; &#160;E<br/>
Sorbose&#160;(L)&#160;resistance<br/>
715<br/>
&#160; L<br/>
<i>fts</i>&#160;(generic)<br/>
&#160; &#160;E<br/>
Filter&#160;retention<br/>
55<br/>
<i>ftsZ</i><br/>
&#160; &#160;E<br/>
UV&#160;irradiation&#160;resistance&#160;in&#160;<i>lon</i><br/>
373<br/>
<i>ftsZ</i><br/>
&#160; &#160;E<br/>
Methyl&#160;methanesulfonate&#160;resistance&#160;in&#160;<i>lon</i><br/>
373<br/>
<i>ftsZ</i><br/>
&#160; &#160;E<br/>
Nitrofurantoin&#160;resistance&#160;in&#160;<i>lon</i><br/>
252<br/>
<i>fucA</i><br/>
&#160; &#160;E<br/>
Propanediol&#160;as&#160;C&#160;source<br/>
287<br/>
<i>fucA</i><br/>
&#160; &#160;E<br/>
Ethyleneglycol&#160;as&#160;C&#160;source&#160;in&#160;propanediol&#160;utilizer<br/>
79<br/>
<i>fucA</i><br/>
&#160; &#160;E<br/>
Fucose&#160;(L)&#160;as&#160;C&#160;source&#160;in&#160;propanediol&#160;utilizer<br/>
287<br/>
<i>fucA</i><br/>
&#160; &#160;E<br/>
Xylitol&#160;as&#160;C&#160;source&#160;in&#160;propanediol&#160;utilizer<br/>
848<br/>
<i>fucA</i><br/>
&#160; &#160;E<br/>
Arabinose&#160;(D)&#160;as&#160;C&#160;source<br/>
450<br/>
<i>fur</i><br/>
&#160; &#160;E<br/>
Manganese&#160;resistance<br/>
300<br/>
&#160; C<br/>
<i>fusA</i><br/>
&#160; &#160;E<br/>
Fusidic&#160;acid&#160;resistance<br/>
65,&#160;434,&#160;695,&#160;761<br/>
&#160; S<br/>
<i>gabC</i><br/>
&#160; &#160;E<br/>
Aminobutyrate&#160;as&#160;N&#160;source<br/>
197<br/>
<i>gadS</i><br/>
&#160; &#160;E<br/>
Glutamate&#160;as&#160;C&#160;source<br/>
292<br/>
&#160; L<br/>
<i>gal</i>&#160;operon<br/>
&#160; &#160;E<br/>
Galactose&#160;utilization&#160;in&#160;the&#160;presence&#160;of<br/>
636<br/>
&#160; D<br/>
thiomethylglucoside<br/>
<i>gal</i>&#160;operon<br/>
&#160; &#160;S<br/>
Deoxy(2)galactose&#160;resistance<br/>
9,&#160;552<br/>
&#160; L<br/>
<i>gal</i>&#160;operon<br/>
&#160; &#160;E<br/>
Galactose&#160;resistance&#160;in&#160;<i>galU</i><br/>
664<br/>
&#160; L<br/>
<i>galC</i><br/>
&#160; &#160;S<br/>
Glucose&#160;as&#160;C&#160;source&#160;in&#160;∆<i>ptsHI</i><br/>
613<br/>
<i>galE</i><br/>
&#160; &#160;E,&#160;S<br/>
P1&#160;phage&#160;infection&#160;of&#160;<i>Salmonella</i>&#160;sp.&#160;monitored&#160;by&#160;drug<br/>
527<br/>
&#160; L<br/>
resistance<br/>
<i>galE</i><br/>
&#160; &#160;E<br/>
U3&#160;phage&#160;resistance<br/>
816<br/>
&#160; L<br/>
<i>galE</i><br/>
&#160; &#160;S<br/>
Deoxy(2)galactose&#160;resistance<br/>
408<br/>
&#160; L<br/>
<i>galE</i><br/>
&#160; &#160;S<br/>
Felix&#160;O&#160;phage&#160;resistance<br/>
334,&#160;527,&#160;591,&#160;833<br/>
&#160; L<br/>
<i>galE</i><br/>
&#160; &#160;S<br/>
P22&#160;phage&#160;resistance<br/>
334,&#160;527,&#160;591,&#160;833<br/>
&#160; L<br/>
<i>galK</i><br/>
&#160; &#160;S<br/>
Deoxy(2)galactose&#160;resistance<br/>
408<br/>
&#160; L<br/>
<i>galK</i><br/>
&#160; &#160;E,&#160;S<br/>
Galactose&#160;resistance&#160;in&#160;<i>galE</i><br/>
569,&#160;752<br/>
&#160; L<br/>
<i>galK</i><br/>
&#160; &#160;E<br/>
Galactose&#160;resistance&#160;in&#160;<i>galT</i><br/>
859<br/>
&#160; L<br/>
<i>galK</i><br/>
&#160; &#160;E<br/>
Galactose&#160;resistance&#160;in&#160;<i>galU</i><br/>
664<br/>
&#160; L<br/>
<i>galP</i><br/>
&#160; &#160;S<br/>
Deoxy(2)galactose&#160;resistance<br/>
552<br/>
&#160; L<br/>
<i>galR</i><br/>
&#160; &#160;E<br/>
Thiomethylgalactoside-independent&#160;utilization&#160;of<br/>
108<br/>
galactose&#160;in&#160;<i>galR</i>(Con)<br/>
<i>galR</i><br/>
&#160; &#160;S<br/>
Glucose&#160;utilization&#160;in&#160;∆<i>ptsHI</i><br/>
613<br/>
<i>galR</i><br/>
&#160; &#160;E<br/>
Galactose&#160;resistance&#160;in&#160;<i>galT</i>+<i>K</i>+<i>E</i>+/<i>galT</i>+<i>K</i>+<i>E</i>+&#160;<i>galU</i><br/>
664<br/>
<i>galT</i><br/>
&#160; &#160;E<br/>
Streptozotocin&#160;resistance<br/>
456<br/>
&#160; L<br/>
<hr/>
<a name=32></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>galU</i><br/>
&#160; &#160;E<br/>
Ampicillin&#160;resistance<br/>
212<br/>
&#160; L<br/>
<i>galU</i><br/>
&#160; &#160;E<br/>
P1&#160;phage&#160;resistance<br/>
242<br/>
&#160; L<br/>
<i>galU</i><br/>
&#160; &#160;E<br/>
U3&#160;phage&#160;resistance<br/>
816<br/>
&#160; L<br/>
<i>galU</i><br/>
&#160; &#160;S<br/>
Felix&#160;O&#160;phage&#160;resistance<br/>
334<br/>
&#160; L<br/>
<i>garA</i><br/>
&#160; &#160;S<br/>
Gamma&#160;irradiation&#160;resistance<br/>
346<br/>
<i>garA</i><br/>
&#160; &#160;E<br/>
Glucarate&#160;(D)&#160;resistance&#160;in&#160;<i>ppc</i><br/>
647<br/>
&#160; L<br/>
<i>garB</i><br/>
&#160; &#160;S<br/>
Gamma&#160;irradiation&#160;resistance<br/>
346<br/>
<i>gatACD</i><br/>
&#160; &#160;E<br/>
Fucitol&#160;resistance&#160;in&#160;galactitol-utilizing&#160;strains<br/>
184<br/>
&#160; L<br/>
<i>gatACD</i><br/>
&#160; &#160;E<br/>
Deoxy(2)galactitol&#160;resistance&#160;in&#160;galactitol-utilizing<br/>
184<br/>
&#160; L<br/>
strains<br/>
<i>gatACD</i><br/>
&#160; &#160;E<br/>
Arabitol&#160;utilization<br/>
466,&#160;845<br/>
<i>gatACD</i><br/>
&#160; &#160;E<br/>
Ribitol&#160;utilization<br/>
466,&#160;845<br/>
<i>gatACD</i><br/>
&#160; &#160;E<br/>
Arbitol&#160;(D)&#160;resistance<br/>
639<br/>
&#160; L<br/>
<i>gleR</i><br/>
&#160; &#160;S<br/>
Glycylleucine&#160;resistance&#160;in&#160;<i>ilv</i><br/>
580<br/>
<i>glnA</i><br/>
&#160; &#160;S<br/>
Histidine(D)&#160;+&#160;glycylglutamine&#160;satisfaction&#160;of&#160;<i>his</i><br/>
819<br/>
&#160; L<br/>
auxotrophs<br/>
<i>glnA</i><br/>
&#160; &#160;E<br/>
Methylammonium&#160;resistance<br/>
694<br/>
&#160; S<br/>
<i>glnA</i><br/>
&#160; &#160;E<br/>
Methionine&#160;sulfoxamine&#160;resistance&#160;in&#160;<i>glnG</i><br/>
592<br/>
&#160; C<br/>
<i>glnA</i><br/>
&#160; &#160;S<br/>
Glutamyl(γ)hydrazide&#160;resistance<br/>
518;&#160;Miller<i>f</i><br/>
&#160; S<br/>
<i>glnF</i><br/>
&#160; &#160;S<br/>
Glutamyl(γ)hydrazide&#160;resistance<br/>
433<br/>
&#160; L<br/>
<i>glnH</i><br/>
&#160; &#160;S<br/>
433<br/>
&#160; L<br/>
Glutamyl(γ)hydrazide&#160;resistance<br/>
<i>glnP</i><br/>
&#160; &#160;E<br/>
Glutamine&#160;as&#160;C&#160;source<br/>
433,&#160;501,&#160;820<br/>
<i>glnP</i><br/>
&#160; &#160;E,&#160;S<br/>
Methionine&#160;sulfoxamine&#160;resistance<br/>
37,&#160;501<br/>
&#160; L<br/>
<i>glnP</i><br/>
&#160; &#160;E<br/>
Glutamyl(γ)hydrazide&#160;resistance<br/>
501,&#160;821<br/>
&#160; L<br/>
<i>glnP</i><br/>
&#160; &#160;E<br/>
Glutamine&#160;(D)&#160;resistance<br/>
501<br/>
&#160; L<br/>
<i>glnV</i><br/>
&#160; &#160;E<br/>
Caffeine&#160;resistance<br/>
185<br/>
&#160; S<br/>
<i>glpD</i><br/>
&#160; &#160;E<br/>
Streptozotocin&#160;resistance<br/>
456<br/>
&#160; L<br/>
<i>glpF</i><br/>
&#160; &#160;E<br/>
Glyceraldehyde&#160;(L)&#160;resistance<br/>
762<br/>
&#160; L<br/>
<i>glpK</i><br/>
&#160; &#160;E<br/>
Glyceraldehyde&#160;(L)&#160;resistance<br/>
762<br/>
&#160; L<br/>
<i>glpK</i><br/>
&#160; &#160;E,&#160;S<br/>
Methyl(α)glucoside-resistant&#160;glycerol&#160;utilization&#160;in&#160;<i>ptsI</i><br/>
64,&#160;665<br/>
<i>glpT</i><br/>
&#160; &#160;E,&#160;S<br/>
Fosfomycin&#160;resistance<br/>
10,&#160;29,&#160;313,&#160;707,<br/>
&#160; L<br/>
800<br/>
<i>glpT</i><br/>
&#160; &#160;E<br/>
Glyceraldehyde&#160;(DL)&#160;3-phosphate&#160;resistance<br/>
762<br/>
&#160; L<br/>
<i>glpT</i><br/>
&#160; &#160;E<br/>
Arsenate&#160;resistance<br/>
838<br/>
&#160; L<br/>
<i>glpT</i><br/>
&#160; &#160;E<br/>
Dihydroxybutyl&#160;phosphonate&#160;resistance<br/>
285,&#160;453<br/>
&#160; L<br/>
<i>glpT</i><br/>
&#160; &#160;E<br/>
Fluorohydroxyacetone&#160;phosphate&#160;resistance<br/>
515<br/>
&#160; L<br/>
<i>glpT</i><br/>
&#160; &#160;E<br/>
Chlorohydroxyacetone&#160;phosphate&#160;resistance<br/>
515<br/>
&#160; L<br/>
<i>glpT</i><br/>
&#160; &#160;E<br/>
Glycerol&#160;3-phosphorothioate&#160;resistance<br/>
295<br/>
&#160; L<br/>
<i>gltA</i><br/>
&#160; &#160;E<br/>
Improved&#160;growth&#160;in&#160;<i>icd</i><br/>
435<br/>
&#160; L<br/>
<i>gltH</i><br/>
&#160; &#160;E<br/>
Glutamate&#160;as&#160;C&#160;source<br/>
496,&#160;497,&#160;687<br/>
<i>gltR</i><br/>
&#160; &#160;E<br/>
Glutamate&#160;as&#160;C&#160;source&#160;at&#160;42°C<br/>
497<br/>
<i>gltS</i><br/>
&#160; &#160;E<br/>
Glutamate&#160;as&#160;C&#160;source<br/>
496,&#160;687<br/>
&#160; Q<br/>
<i>gltS</i><br/>
&#160; &#160;E<br/>
Glutamate&#160;as&#160;C&#160;source<br/>
496,&#160;497,&#160;687<br/>
<i>gltS</i><br/>
&#160; &#160;E<br/>
Glutamate&#160;(D)&#160;resistance&#160;in&#160;<i>gltS</i>&#160;(increased)<br/>
525,&#160;716<br/>
&#160; L<br/>
<i>gltS</i><br/>
&#160; &#160;E<br/>
Methyl(α)glutamate&#160;resistance&#160;in&#160;<i>gltS</i>&#160;(increased)<br/>
391,&#160;525,&#160;716<br/>
&#160; L<br/>
<i>gltS</i><br/>
&#160; &#160;E<br/>
Homocysteic&#160;acid&#160;resistance<br/>
213<br/>
&#160; L<br/>
<i>gltX</i><br/>
&#160; &#160;E<br/>
Glutamyl-γ-methyl&#160;ester&#160;resistance<br/>
425<br/>
<i>glyA</i><br/>
&#160; &#160;E<br/>
Serine&#160;+&#160;methionine&#160;+&#160;glycine&#160;resistance&#160;in&#160;<i>relA</i><br/>
783<br/>
<i>gntM</i><br/>
&#160; &#160;E<br/>
Glycerol&#160;+&#160;gluconate&#160;as&#160;C&#160;source&#160;in&#160;<i>eda</i><br/>
217<br/>
&#160; L<br/>
<i>gntR</i><br/>
&#160; &#160;E<br/>
Acetate&#160;+&#160;gluconate&#160;as&#160;C&#160;source&#160;in&#160;<i>ppc</i><br/>
39<br/>
<i>gntS</i><br/>
&#160; &#160;E<br/>
Acetate&#160;+&#160;gluconate&#160;as&#160;C&#160;source&#160;in&#160;<i>ppc</i><br/>
39<br/>
&#160; L<br/>
<i>gor</i><br/>
&#160; &#160;E<br/>
Methyl&#160;viologen&#160;tolerance<br/>
430<br/>
&#160; L<br/>
<i>gprAB</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;resistance<br/>
578,&#160;670<br/>
<i>gpt</i><br/>
&#160; &#160;S<br/>
Aza(8)guanine&#160;resistance<br/>
272,&#160;764<br/>
&#160; L<br/>
<i>gpt</i><br/>
&#160; &#160;E<br/>
Sulfanilamide&#160;resistance&#160;in&#160;presence&#160;of&#160;guanine<br/>
97<br/>
&#160; L<br/>
<i>groM</i><br/>
&#160; &#160;E<br/>
T7&#160;phage&#160;resistance<br/>
427<br/>
<hr/>
<a name=33></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>grpD</i><br/>
&#160; &#160;E<br/>
Lambda&#160;mutant&#160;prophage&#160;induction,&#160;survival&#160;of<br/>
667<br/>
<i>grpE</i><br/>
&#160; &#160;E<br/>
Lambda&#160;mutant&#160;prophage&#160;induction,&#160;survival&#160;of<br/>
667<br/>
<i>gsh</i>&#160;(generic)<br/>
&#160; &#160;E<br/>
Nitrosoguanidine&#160;resistance<br/>
693<br/>
&#160; L<br/>
<i>gsh</i>&#160;(generic)<br/>
&#160; &#160;E<br/>
Methylglyoxal&#160;resistance<br/>
548<br/>
<i>gshAB</i><br/>
&#160; &#160;E,&#160;S<br/>
Selenite&#160;resistance<br/>
423<br/>
&#160; L<br/>
<i>guaAB</i><br/>
&#160; &#160;E<br/>
Psicofuranine&#160;resistance<br/>
779<br/>
<i>guaB</i><br/>
&#160; &#160;S<br/>
Fluoro(5)uracil&#160;+&#160;fluoro(5)uridine&#160;resistance<br/>
367<br/>
&#160; L<br/>
<i>gurBCD</i><br/>
&#160; &#160;E<br/>
Glycerol&#160;+&#160;methylglucuronide&#160;a&#160;C&#160;source&#160;in&#160;<i>eda</i><br/>
572<br/>
&#160; L<br/>
<i>gyrA</i><br/>
&#160; &#160;E,&#160;S<br/>
Triazolealanine&#160;+&#160;aminotriazole&#160;resistance<br/>
660<br/>
&#160; S<br/>
<i>gyrA</i><br/>
&#160; &#160;E,&#160;S<br/>
Nalidixic&#160;acid&#160;resistance<br/>
200,&#160;298<br/>
&#160; S<br/>
<i>gyrA</i><br/>
&#160; &#160;E<br/>
Quinolone&#160;resistance<br/>
860<br/>
&#160; S<br/>
<i>gyrA</i><br/>
&#160; &#160;E<br/>
Oxolinic&#160;acid&#160;resistance<br/>
734<br/>
&#160; S<br/>
<i>gyrA</i><br/>
&#160; &#160;E<br/>
Glucosides&#160;(β)&#160;as&#160;C&#160;source<br/>
194<br/>
<i>gyrA</i><br/>
&#160; &#160;S<br/>
Thermotolerance<br/>
200<br/>
<i>gyrB</i><br/>
&#160; &#160;S<br/>
Triaolealanine&#160;+&#160;aminotriazole&#160;resistance<br/>
660<br/>
&#160; S<br/>
<i>gyrB</i><br/>
&#160; &#160;E<br/>
Aminotriazole&#160;resistance&#160;in&#160;<i>relA</i><br/>
772<br/>
&#160; S<br/>
<i>gyrB</i><br/>
&#160; &#160;E<br/>
Novobiocin&#160;resistance<br/>
255<br/>
&#160; S<br/>
<i>gyrB</i><br/>
&#160; &#160;E<br/>
Coumermycin&#160;resistance<br/>
181,&#160;255,&#160;593<br/>
&#160; D,&#160;S<br/>
<i>gyrB</i><br/>
&#160; &#160;E<br/>
Chlorobiocin&#160;resistance<br/>
589<br/>
<i>gyrB</i><br/>
&#160; &#160;E<br/>
Glucosides&#160;(β)&#160;as&#160;C&#160;source<br/>
194<br/>
<i>gyrB</i><br/>
&#160; &#160;E<br/>
Lambda&#160;mutant&#160;infection&#160;resistance<br/>
521<br/>
<i>gyrB</i><br/>
&#160; &#160;E<br/>
Nalidixic&#160;acid&#160;resistance<br/>
333,&#160;855<br/>
&#160; S<br/>
<i>hem</i><br/>
&#160; &#160;E<br/>
Streptomycin&#160;resistance<br/>
57<br/>
&#160; L<br/>
(generic)<br/>
<i>hemA</i><br/>
&#160; &#160;E<br/>
Kanamycin&#160;resistance<br/>
585<br/>
&#160; L<br/>
<i>hemA</i><br/>
&#160; &#160;E,&#160;S<br/>
Neomycin&#160;resistance<br/>
683<br/>
&#160; L<br/>
<i>hemB</i><br/>
&#160; &#160;E<br/>
Kanamycin&#160;resistance<br/>
585<br/>
&#160; L<br/>
<i>hemB</i><br/>
&#160; &#160;E<br/>
Kanamycin-resistant,&#160;hemin-supported&#160;growth&#160;of&#160;<i>hemA</i><br/>
507<br/>
&#160; L<br/>
<i>hemB</i><br/>
&#160; &#160;E<br/>
Colicin&#160;“&#160;K-type”&#160;&#160;tolerance<br/>
83<br/>
<i>hemC</i><br/>
&#160; &#160;S<br/>
Neomycin&#160;resistance<br/>
682<br/>
&#160; L<br/>
<i>hemD</i><br/>
&#160; &#160;S<br/>
Neomycin&#160;resistance<br/>
681<br/>
&#160; L<br/>
<i>hemE</i><br/>
&#160; &#160;S<br/>
Neomycin&#160;resistance<br/>
189,&#160;680<br/>
&#160; L<br/>
<i>hemBCF</i><br/>
&#160; &#160;E<br/>
Plate&#160;method<br/>
506<br/>
&#160; L<br/>
<i>hemG</i><br/>
&#160; &#160;E<br/>
Neomycin&#160;resistance<br/>
679<br/>
&#160; L<br/>
<i>hemL</i><br/>
&#160; &#160;E<br/>
Kanamycin&#160;resistance<br/>
350<br/>
&#160; L<br/>
<i>hflC</i><br/>
&#160; &#160;E<br/>
Lambda&#160;mutant&#160;phage&#160;resistance<br/>
56<br/>
<i>hflK</i><br/>
&#160; &#160;E<br/>
Lambda&#160;mutant&#160;phage&#160;resistance<br/>
56<br/>
<i>hflX</i><br/>
&#160; &#160;E<br/>
Lambda&#160;mutant&#160;phage&#160;resistance<br/>
56<br/>
<i>himA</i><br/>
&#160; &#160;E<br/>
Mu&#160;prophage&#160;induction,&#160;survival&#160;of<br/>
520,&#160;522<br/>
<i>himA</i><br/>
&#160; &#160;E<br/>
Mu&#160;phage&#160;lytic&#160;growth&#160;resistance<br/>
81<br/>
<i>himA</i><br/>
&#160; &#160;E<br/>
Lambda&#160;mutant&#160;phage&#160;infection,&#160;survival&#160;of<br/>
519,&#160;521<br/>
<i>himA&#160;(himC)</i><br/>
&#160; &#160;E<br/>
Lambda&#160;mutant&#160;phage&#160;resistance<br/>
519,&#160;521<br/>
<i>himD</i><br/>
&#160; &#160;E<br/>
Mu&#160;prophage&#160;induction,&#160;survival&#160;of<br/>
520,&#160;522<br/>
<i>himD</i><br/>
&#160; &#160;E<br/>
Mu&#160;phage&#160;lytic&#160;growth&#160;resistance<br/>
81<br/>
<i>hipA</i><br/>
&#160; &#160;E<br/>
Cycloserine&#160;resistance<br/>
541<br/>
<i>hipA</i><br/>
&#160; &#160;E<br/>
Ampicillin&#160;resistance<br/>
541<br/>
<i>hipA</i><br/>
&#160; &#160;E<br/>
Fosfomycin&#160;resistance<br/>
541<br/>
<i>hipQ</i><br/>
&#160; &#160;E<br/>
Norfloxacin&#160;resistance<br/>
842<br/>
<i>hipQ</i><br/>
&#160; &#160;E<br/>
Ampicillin&#160;resistance<br/>
842<br/>
<i>his</i>&#160;structural<br/>
&#160; &#160;E,&#160;S<br/>
Triazolealanine&#160;+&#160;aminotriazole&#160;resistance<br/>
98,&#160;126,&#160;658<br/>
&#160; C,&#160;Q<br/>
genes<br/><i>his</i>&#160;structural<br/>
&#160; &#160;S<br/>
Aminotriazole&#160;resistance<br/>
20,&#160;21<br/>
&#160; D<br/>
genes<br/><i>his</i>&#160;structural<br/>
&#160; &#160;S<br/>
Growth&#160;at&#160;42°C&#160;in&#160;<i>his</i>-overexpressing&#160;strain<br/>
804<br/>
&#160; Q<br/>
genes<br/><i>his</i>&#160;structural<br/>
&#160; &#160;S<br/>
Histidinal&#160;satisfaction&#160;of&#160;<i>his</i>&#160;auxotroph&#160;requirement&#160;at<br/>
374,&#160;375<br/>
&#160; Q<br/>
genes<br/>
30°C<br/>
<i>his</i>&#160;structural<br/>
&#160; &#160;S<br/>
Histidine&#160;(D)&#160;satisfaction&#160;of&#160;<i>his</i>&#160;auxotroph&#160;requirement<br/>
374,&#160;375<br/>
&#160; Q<br/>
genes<br/>
<hr/>
<a name=34></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>hisG</i><br/>
&#160; &#160;E,&#160;S<br/>
Thiazolealanine&#160;resistance<br/>
540,&#160;698,&#160;824<br/>
&#160; S,&#160;FBI<br/>
<i>hisG</i><br/>
&#160; &#160;S<br/>
Hydrazino&#160;(α)&#160;imidazole&#160;propionic&#160;acid&#160;resistance<br/>
699<br/>
&#160; S,&#160;FBI<br/>
<i>hisG</i><br/>
&#160; &#160;S<br/>
Histidinal&#160;satisfaction&#160;of&#160;<i>his</i>&#160;auxotroph&#160;requirement&#160;at<br/>
374,&#160;375<br/>
&#160; L<br/>
30°C<br/>
<i>hisG</i><br/>
&#160; &#160;S<br/>
Histidine&#160;(D)&#160;satisfaction&#160;of&#160;<i>his</i>&#160;auxotroph&#160;requirement<br/>
374,&#160;375<br/>
&#160; L<br/>
<i>hisG</i><br/>
&#160; &#160;E<br/>
Histidine-resistant&#160;adenine&#160;→&#160;guanine&#160;nucleotide<br/>
33<br/>
&#160; S,FBI<br/>
conversion&#160;in&#160;<i>deoD&#160;purF&#160;add</i><br/>
<i>hisJ</i><br/>
&#160; &#160;S<br/>
Hydrazino&#160;(α)&#160;imidazole&#160;propionic&#160;acid&#160;resistance<br/>
13,&#160;15<br/>
&#160; L<br/>
<i>hisJ</i><br/>
&#160; &#160;S<br/>
Azaserine&#160;+&#160;tryptophan&#160;resistance&#160;in&#160;<i>dhuA</i><br/>
15,&#160;432<br/>
<i>hisP</i><br/>
&#160; &#160;S<br/>
Hydrazino&#160;(α)&#160;imidazole&#160;propionic&#160;acid&#160;resistance&#160;in<br/>
14,&#160;15<br/>
&#160; L<br/>
<i>dhuA</i><br/>
<i>hisP</i><br/>
&#160; &#160;S<br/>
Arginine&#160;as&#160;N&#160;source<br/>
13,&#160;15,&#160;432<br/>
&#160; D<br/>
<i>hisQ</i><br/>
&#160; &#160;S<br/>
Hydrazino&#160;(α)&#160;imidazole&#160;propionic&#160;acid&#160;resistance<br/>
13,&#160;15<br/>
&#160; L<br/>
<i>hisR</i><br/>
&#160; &#160;S<br/>
Triazolealanine&#160;+&#160;aminotriazole&#160;resistance<br/>
658<br/>
&#160; Q<br/>
<i>hisR</i><br/>
&#160; &#160;S<br/>
Thiazolealanine&#160;resistance<br/>
706<br/>
&#160; Q<br/>
<i>hisR</i><br/>
&#160; &#160;S<br/>
Methyl(2)histidine&#160;resistance&#160;+&#160;aminotriazole&#160;resistance<br/>
658<br/>
&#160; Q<br/>
<i>hisS</i><br/>
&#160; &#160;S<br/>
Triazolealanine&#160;+&#160;aminotriazole&#160;resistance<br/>
658<br/>
&#160; S<br/>
<i>hisS</i><br/>
&#160; &#160;S<br/>
Thiazolealanine&#160;resistance<br/>
657<br/>
&#160; S<br/>
<i>hisT</i><br/>
&#160; &#160;E,&#160;S<br/>
Triazolealanine&#160;+&#160;aminotriazole&#160;resistance<br/>
98,&#160;148,&#160;658,&#160;705,<br/>
&#160; L<br/>
784<br/>
<i>hisT</i><br/>
&#160; &#160;E<br/>
Azaleucine&#160;resistance<br/>
98,&#160;784<br/>
&#160; L<br/>
<i>hisT</i><br/>
&#160; &#160;E<br/>
Serine&#160;resistance<br/>
98,&#160;784<br/>
&#160; L<br/>
<i>hisT</i><br/>
&#160; &#160;S<br/>
Amino(3)tyrosine&#160;resistance<br/>
148,&#160;658,&#160;705<br/>
&#160; L<br/>
<i>hisT</i><br/>
&#160; &#160;S<br/>
Thialysine&#160;resistance<br/>
148,&#160;658,&#160;705<br/>
&#160; L<br/>
<i>hisT</i><br/>
&#160; &#160;S<br/>
Trifluoroleucine&#160;resistance<br/>
148,&#160;658,&#160;705<br/>
&#160; L<br/>
<i>hisT</i><br/>
&#160; &#160;S<br/>
Norleucine&#160;resistance<br/>
148,&#160;658,&#160;705<br/>
&#160; L<br/>
<i>hisT</i><br/>
&#160; &#160;S<br/>
Hydroxy&#160;(β)&#160;leucine&#160;resistance<br/>
148,&#160;658,&#160;705<br/>
&#160; L<br/>
<i>hisT</i><br/>
&#160; &#160;E<br/>
Phenyl&#160;galactoside&#160;resistance&#160;of&#160;<i>lacP&#160;lacI</i>&#160;(nonsense)<br/>
747<br/>
<i>supE</i><br/>
<i>hisU</i><br/>
&#160; &#160;S,&#160;E<br/>
Triazolealanine&#160;+&#160;aminotriazole&#160;resistance<br/>
23,&#160;660<br/>
<i>hisU</i><br/>
&#160; &#160;S<br/>
Nalidixic&#160;acid&#160;resistance<br/>
593,&#160;660<br/>
<i>hisW</i><br/>
&#160; &#160;S,&#160;E<br/>
Triazolealanine&#160;+&#160;aminotriazole&#160;resistance<br/>
23<br/>
<i>hisW</i><br/>
&#160; &#160;S<br/>
Coumermycin&#160;resistance<br/>
593,&#160;660<br/>
<i>hpt</i><br/>
&#160; &#160;E<br/>
Mercapto(6)purine&#160;resistance&#160;in&#160;<i>gpt</i><br/>
371<br/>
<i>hpt</i><br/>
&#160; &#160;E<br/>
Sulfanilamide&#160;+&#160;hypoxanthine&#160;resistance<br/>
97<br/>
&#160; L<br/>
<i>hsd</i><br/>
&#160; &#160;E<br/>
Lambda&#160;<i>vir</i>&#160;resistance&#160;after&#160;infection&#160;with<br/>
183<br/>
&#160; L<br/>
heteromodified&#160;lambda&#160;<i>c</i>I857<br/>
<i>hsd</i><br/>
&#160; &#160;S<br/>
Lactose&#160;utilization&#160;after&#160;conjugation&#160;of&#160;<i>F</i>′<i>lac</i>&#160;into<br/>
103<br/>
&#160; L<br/>
<i>Salmonella</i>&#160;sp.<br/>
<i>hut</i><br/>
&#160; &#160;S<br/>
Histidine&#160;as&#160;sole&#160;N&#160;or&#160;C&#160;source<br/>
509<br/>
<i>icdE</i><br/>
&#160; &#160;E,&#160;S<br/>
Nalidixic&#160;acid&#160;resistance<br/>
91,&#160;311<br/>
&#160; L<br/>
<i>iclR</i><br/>
&#160; &#160;E<br/>
Butyrate&#160;or&#160;valerate&#160;as&#160;better&#160;C&#160;source<br/>
602<br/>
&#160; C<br/>
<i>iclR</i><br/>
&#160; &#160;E<br/>
Glucose&#160;or&#160;glycerol&#160;as&#160;C&#160;source&#160;in&#160;<i>ppc</i><br/>
488<br/>
<i>ileR</i><br/>
&#160; &#160;E<br/>
Trifluoroleucine&#160;resistance<br/>
412<br/>
<i>ileS</i><br/>
&#160; &#160;E<br/>
Pseudomonic&#160;acid&#160;resistance<br/>
858<br/>
&#160; S<br/>
<i>ileS</i><br/>
&#160; &#160;E<br/>
Thiaisoleucine&#160;resistance<br/>
757<br/>
&#160; S<br/>
<i>ilv</i>&#160;structural<br/>
&#160; &#160;S<br/>
Sulfometuron&#160;methyl&#160;+&#160;valine&#160;resistance<br/>
Epelbaum&#160;et&#160;al.<i>g</i><br/>
&#160; C<br/>
genes<br/><i>ilv</i>&#160;structural<br/>
&#160; &#160;E<br/>
Aminobutyrate&#160;resistance<br/>
633,&#160;780<br/>
&#160; C<br/>
genes<br/><i>ilv</i>&#160;structural<br/>
&#160; &#160;E<br/>
Valine&#160;resistance<br/>
268<br/>
&#160; C<br/>
genes<br/><i>ilv</i>&#160;structural<br/>
&#160; &#160;S<br/>
Cyclopentane&#160;glycine&#160;resistance<br/>
586<br/>
&#160; C<br/>
genes<br/>
<i>ilvA</i><br/>
&#160; &#160;S<br/>
Cyclopentane&#160;glycine&#160;resistance<br/>
586<br/>
&#160; S,&#160;FBI<br/>
<i>ilvA</i><br/>
&#160; &#160;E<br/>
Glyclleucine&#160;resistance<br/>
806<br/>
&#160; S,&#160;FBI<br/>
<hr/>
<a name=35></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>ilvA</i><br/>
&#160; &#160;S<br/>
Threonine&#160;as&#160;sole&#160;N&#160;source<br/>
106<br/>
&#160; S,&#160;FBI<br/>
<i>ilvA</i><br/>
&#160; &#160;E<br/>
Growth&#160;on&#160;minimal&#160;medium&#160;of&#160;<i>ilvA+</i>&#160;(multicopy)&#160;<i>ilvDC</i><br/>
231<br/>
&#160; L<br/>
<i>hisT</i>&#160;overcoming&#160;2-ketobutyrate&#160;accumulation<br/>
<i>ilvB</i><br/>
&#160; &#160;E<br/>
Aminobutyrate&#160;resistance<br/>
633,&#160;780<br/>
&#160; S,&#160;FBI<br/>
<i>ilvB</i><br/>
&#160; &#160;E<br/>
Valine&#160;resistance<br/>
633,&#160;755<br/>
&#160; S,&#160;FBI<br/>
<i>ilvB</i><br/>
&#160; &#160;E<br/>
Glyclleucine&#160;resistance<br/>
269<br/>
&#160; S<br/>
<i>ilvB</i><br/>
&#160; &#160;E<br/>
Phenylalanylleucine&#160;resistance<br/>
269<br/>
&#160; S<br/>
<i>ilvF</i><br/>
&#160; &#160;E<br/>
Valine&#160;resistance<br/>
174,&#160;610<br/>
&#160; G<br/>
<i>ilvG</i><br/>
&#160; &#160;E,&#160;S<br/>
Sulfometuron&#160;methyl&#160;+&#160;valine&#160;resistance<br/>
441,&#160;851;<br/>
&#160; S,&#160;Q<br/>
Epelbaum&#160;et&#160;al.<i>g</i><br/>
<i>ilvG</i><br/>
&#160; &#160;E<br/>
Valine&#160;resistance<br/>
221,&#160;448,&#160;720<br/>
&#160; G<br/>
<i>ilvH</i><br/>
&#160; &#160;E<br/>
Aminobutyrate&#160;resistance<br/>
633,&#160;780<br/>
&#160; S,&#160;FBI<br/>
<i>ilvH</i><br/>
&#160; &#160;E<br/>
Valine&#160;resistance<br/>
633,&#160;755<br/>
&#160; S,&#160;FBI<br/>
<i>ilvH</i><br/>
&#160; &#160;E<br/>
Glyclleucine&#160;resistance<br/>
269<br/>
&#160; S<br/>
<i>ilvH</i><br/>
&#160; &#160;E<br/>
Phenylalanylleucine&#160;resistance<br/>
269<br/>
&#160; S<br/>
<i>ilvI</i><br/>
&#160; &#160;E<br/>
Aminobutyrate&#160;resistance<br/>
633,&#160;780<br/>
&#160; S<br/>
<i>ilvI</i><br/>
&#160; &#160;E<br/>
Valine&#160;resistance<br/>
633,&#160;755<br/>
<i>ilvI</i><br/>
&#160; &#160;E<br/>
Glyclleucine&#160;resistance<br/>
269<br/>
<i>ilvI</i><br/>
&#160; &#160;E<br/>
Phenylalanylleucine&#160;resistance<br/>
269<br/>
<i>ilvJ</i><br/>
&#160; &#160;E<br/>
Valine&#160;resistance<br/>
174,&#160;361,&#160;649<br/>
&#160; G<br/>
<i>ilvU</i><br/>
&#160; &#160;E<br/>
Thiaisoleucine&#160;resistance<br/>
222<br/>
<i>kdgR</i><br/>
&#160; &#160;E<br/>
Keto(2)-3-deoxygluconate&#160;as&#160;C&#160;source<br/>
377,&#160;615<br/>
&#160; C<br/>
<i>kdsA</i><br/>
&#160; &#160;S<br/>
9NA&#160;phage&#160;resistance&#160;in&#160;<i>galE</i><br/>
452,&#160;641<br/>
<i>ksgA</i><br/>
&#160; &#160;E<br/>
Kasugamycin&#160;resistance<br/>
312,&#160;726,&#160;793<br/>
&#160; L<br/>
<i>ksgB</i><br/>
&#160; &#160;E<br/>
Kasugamycin&#160;resistance<br/>
238,&#160;726<br/>
<i>ksgC</i><br/>
&#160; &#160;E<br/>
Kasugamycin&#160;resistance<br/>
861<br/>
<i>ksgD</i><br/>
&#160; &#160;E<br/>
Kasugamycin&#160;resistance<br/>
238<br/>
<i>lac</i><br/>
&#160; &#160;E<br/>
Growth&#160;in&#160;lactose-limited&#160;chemostats<br/>
330<br/>
&#160; D<br/>
<i>lacI,</i><br/>
&#160; &#160;E<br/>
Methyl(α)glucoside-resistant&#160;utilization&#160;of&#160;lactose&#160;in<br/>
665<br/>
&#160; C<br/>
operator<br/>
<i>ptsH</i><br/>
<i>lacI,</i><br/>
&#160; &#160;E<br/>
Raffinose&#160;as&#160;C&#160;source<br/>
459<br/>
&#160; C<br/>
operator<br/><i>lacI,</i><br/>
&#160; &#160;E<br/>
Neolactose&#160;as&#160;C&#160;source<br/>
459<br/>
&#160; C<br/>
operator<br/><i>lacI,</i><br/>
&#160; &#160;E<br/>
Phenyl&#160;galactoside&#160;as&#160;C&#160;source<br/>
523<br/>
&#160; C<br/>
operator<br/><i>lacI,</i><br/>
&#160; &#160;E<br/>
Lactobionic&#160;acid&#160;as&#160;C&#160;source<br/>
440<br/>
&#160; C<br/>
operator<br/><i>lacI,</i><br/>
&#160; &#160;E<br/>
Lactitol&#160;as&#160;C&#160;source<br/>
457<br/>
&#160; C<br/>
operator<br/><i>lacI,</i><br/>
&#160; &#160;E<br/>
Melibiose&#160;as&#160;C&#160;source<br/>
475<br/>
&#160; C<br/>
operator<br/><i>lacI,</i><br/>
&#160; &#160;E<br/>
Melibiose&#160;as&#160;C&#160;source&#160;and&#160;acetyl(<i>N</i>)lactonate&#160;as&#160;N<br/>
475<br/>
&#160; C<br/>
operator<br/>
source<br/>
<i>lacI</i>,<br/>
&#160; &#160;E<br/>
Lactobionic&#160;acid&#160;as&#160;C&#160;source<br/>
474<br/>
operator<br/><i>lacI</i>,<br/>
&#160; &#160;E<br/>
Acetyl(<i>N</i>)lactonate&#160;as&#160;N&#160;source<br/>
474<br/>
&#160; Q<br/>
operator<br/><i>lacI</i>,<br/>
&#160; &#160;E<br/>
Nitro(<i>o</i>)-phenylthiogalactoside&#160;resistance&#160;in&#160;<i>lacI</i>(Con)<br/>
543,&#160;571<br/>
&#160; Q<br/>
operator<br/>
or&#160;<i>lacO</i>(Con)<br/>
<i>lacI</i>,<br/>
&#160; &#160;E<br/>
Methyl(α)glucoside-resistant&#160;lactose&#160;utilization<br/>
406<br/>
&#160; C<br/>
operator<br/>
<i>lacY</i><br/>
&#160; &#160;E<br/>
Nitro(<i>o</i>)-phenylthiogalactoside&#160;resistance<br/>
523,&#160;543,&#160;721<br/>
&#160; L<br/>
<i>lacY</i><br/>
&#160; &#160;E<br/>
Phenyl&#160;galactoside&#160;resistance<br/>
376<br/>
&#160; L<br/>
<i>lacY</i><br/>
&#160; &#160;E<br/>
Phenethylyl&#160;galactoside&#160;resistance<br/>
376<br/>
&#160; L<br/>
<i>lacY</i><br/>
&#160; &#160;E<br/>
Arabinose&#160;(L)&#160;growth&#160;in&#160;the&#160;presence&#160;of&#160;<i>lac</i>&#160;operon<br/>
812<br/>
&#160; L<br/>
inducer<br/>
<i>lacY</i><br/>
&#160; &#160;E<br/>
Thiodigalactoside&#160;resistance<br/>
241<br/>
<i>lacZ</i><br/>
&#160; &#160;E<br/>
Lactobionic&#160;acid&#160;as&#160;C&#160;source<br/>
440<br/>
&#160; D<br/>
<i>lacZ</i><br/>
&#160; &#160;E<br/>
Phenyl&#160;galactoside&#160;resistance<br/>
376,&#160;500<br/>
&#160; L<br/>
<i>lacZ</i><br/>
&#160; &#160;E<br/>
Phenethylyl&#160;galactoside&#160;resistance<br/>
376,&#160;500<br/>
&#160; L<br/>
<i>lacZ</i><br/>
&#160; &#160;E<br/>
Nitro(<i>o</i>)-phenyl&#160;galactoside&#160;resistance<br/>
376,&#160;500<br/>
&#160; L<br/>
<hr/>
<a name=36></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>lamB</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;resistance<br/>
88,&#160;134,&#160;135,&#160;253,<br/>
&#160; L,&#160;S<br/>
644,&#160;766<br/>
<i>lamB</i><br/>
&#160; &#160;E<br/>
K10&#160;phage&#160;resistance<br/>
644<br/>
<i>lamB</i><br/>
&#160; &#160;E<br/>
Thio(5)maltose&#160;resistance<br/>
223<br/>
&#160; L<br/>
<i>lct</i><br/>
&#160; &#160;E<br/>
Vinylglycolate&#160;resistance<br/>
696<br/>
<i>leuA</i><br/>
&#160; &#160;S<br/>
Trifluoroleucine&#160;resistance<br/>
115<br/>
&#160; FBI,&#160;S<br/>
<i>leuJ</i><br/>
&#160; &#160;E<br/>
Trifluoroleucine&#160;resistance<br/>
575<br/>
<i>leu</i><br/>
&#160; &#160;S<br/>
Trifluoroleucine&#160;resistance<br/>
115,&#160;116<br/>
&#160; C<br/>
(structural<br/>genes)<br/>
<i>leuS</i><br/>
&#160; &#160;S,&#160;E<br/>
Azaleucine&#160;resistance<br/>
477,&#160;514<br/>
&#160; S<br/>
<i>leuS</i><br/>
&#160; &#160;S<br/>
Trifluoroleucine&#160;resistance<br/>
7<br/>
&#160; S<br/>
<i>leuW</i><br/>
&#160; &#160;E<br/>
Calmodulin&#160;inhibitor&#160;resistance<br/>
129<br/>
&#160; S<br/>
<i>lev</i><br/>
&#160; &#160;E<br/>
Levallorphan&#160;resistance<br/>
164<br/>
<i>lexA</i><br/>
&#160; &#160;E<br/>
Mitomycin&#160;C&#160;resistance&#160;of&#160;<i>recA</i>&#160;(SOS-induced)&#160;<i>sfi</i><br/>
538<br/>
&#160; L<br/>
<i>lexA3</i>(Con)<br/>
<i>lig</i><br/>
&#160; &#160;E<br/>
T4&#160;phage&#160;<i>lig</i>&#160;mutant&#160;nibbling&#160;of&#160;colonies&#160;yielding&#160;<i>lig</i><br/>
254<br/>
&#160; Q<br/>
overproducer<br/>
<i>lig</i><br/>
&#160; &#160;E<br/>
T4&#160;phage&#160;<i>lig</i>&#160;mutant&#160;resistance&#160;from&#160;<i>lig</i>&#160;overproducer<br/>
254<br/>
&#160; L<br/>
<i>linB</i><br/>
&#160; &#160;E<br/>
Lincomycin&#160;resistance<br/>
26,&#160;343<br/>
<i>lit</i><br/>
&#160; &#160;E<br/>
T4&#160;mutant&#160;phage&#160;resistance<br/>
143<br/>
<i>livG</i><br/>
&#160; &#160;E<br/>
Azaleucine&#160;resistance<br/>
303,&#160;561<br/>
&#160; L<br/>
<i>livH</i><br/>
&#160; &#160;E<br/>
Valine&#160;resistance&#160;in&#160;<i>leu</i><br/>
17,&#160;595<br/>
&#160; L<br/>
<i>livH</i><br/>
&#160; &#160;E<br/>
Azaleucine&#160;resistance<br/>
561<br/>
&#160; L<br/>
<i>livJ</i><br/>
&#160; &#160;E<br/>
Valine&#160;resistance&#160;in&#160;<i>leu</i><br/>
17,&#160;595<br/>
&#160; L<br/>
<i>livK</i><br/>
&#160; &#160;E<br/>
Valine&#160;resistance&#160;in&#160;<i>leu</i><br/>
17,&#160;595<br/>
&#160; L<br/>
<i>lon</i><br/>
&#160; &#160;E,&#160;S<br/>
Chlorpromazine&#160;resistance<br/>
198,&#160;529<br/>
&#160; L<br/>
<i>lon</i><br/>
&#160; &#160;E<br/>
Promethazine&#160;resistance<br/>
529<br/>
&#160; L<br/>
<i>lpp</i><br/>
&#160; &#160;E<br/>
Globomycin&#160;resistance<br/>
140,&#160;344,&#160;854,&#160;868<br/>
&#160; L<br/>
<i>lpcA</i><br/>
&#160; &#160;E<br/>
T3&#160;phage&#160;resistance<br/>
792<br/>
&#160; L<br/>
<i>lpcA</i><br/>
&#160; &#160;E<br/>
T4&#160;phage&#160;resistance<br/>
792<br/>
&#160; L<br/>
<i>lpcA</i><br/>
&#160; &#160;E<br/>
T7&#160;phage&#160;resistance<br/>
792<br/>
&#160; L<br/>
<i>lpcA</i><br/>
&#160; &#160;E<br/>
P1&#160;phage&#160;resistance<br/>
40,&#160;41<br/>
<i>lpcB</i><br/>
&#160; &#160;E<br/>
T4&#160;phage&#160;resistance<br/>
760<br/>
<i>lpcB</i><br/>
&#160; &#160;E<br/>
T7&#160;phage&#160;resistance<br/>
760<br/>
<i>lrp</i><br/>
&#160; &#160;E<br/>
Leucine&#160;(D)&#160;satisfaction&#160;of&#160;<i>leu</i>&#160;auxotrophs<br/>
18,&#160;428<br/>
<i>lysC</i><br/>
&#160; &#160;E<br/>
Aminoethylcysteine&#160;(thialysine)&#160;resistance<br/>
82,&#160;765<br/>
&#160; S,&#160;FBI<br/>
<i>lysC</i><br/>
&#160; &#160;E<br/>
Lysine&#160;hydroxamate&#160;resistance<br/>
82,&#160;765<br/>
&#160; S,&#160;FBI<br/>
<i>lysP</i><br/>
&#160; &#160;E<br/>
Aminoethylcysteine&#160;(thialysine)&#160;resistance<br/>
611,&#160;736<br/>
&#160; L<br/>
<i>lysS</i><br/>
&#160; &#160;E<br/>
Aminoethylcysteine&#160;(thialysine)&#160;resistance<br/>
323<br/>
&#160; S<br/>
<i>lysS</i><br/>
&#160; &#160;E<br/>
Phenyl&#160;galactoside&#160;resistance&#160;of&#160;<i>lacI&#160;</i>q<i>&#160;lacI</i>(nonsense)<br/>
748<br/>
<i>lacP&#160;supL</i><br/>
<i>lyt</i><br/>
&#160; &#160;E<br/>
Beta-lactam&#160;tolerance<br/>
700<br/>
<i>mac</i><br/>
&#160; &#160;E<br/>
Erythromycin&#160;growth&#160;dependence<br/>
725<br/>
<i>malE</i><br/>
&#160; &#160;E,&#160;S<br/>
Methylglucoside(α)-resistant&#160;utilization&#160;of&#160;maltose<br/>
665<br/>
<i>malE</i><br/>
&#160; &#160;E<br/>
Thio(5)maltose&#160;resistance<br/>
223<br/>
&#160; L<br/>
<i>malF</i><br/>
&#160; &#160;E,&#160;S<br/>
Methylglucoside(α)-resistant&#160;utilization&#160;of&#160;maltose<br/>
665<br/>
<i>malF</i><br/>
&#160; &#160;E<br/>
Thio(5)maltose&#160;resistance<br/>
223<br/>
&#160; L<br/>
<i>malG</i><br/>
&#160; &#160;E,&#160;S<br/>
Methylglucoside(α)-resistant&#160;utilization&#160;of&#160;maltose<br/>
665<br/>
<i>malG</i><br/>
&#160; &#160;E<br/>
Thio(5)maltose&#160;resistance<br/>
223<br/>
&#160; L<br/>
<i>malK</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;resistance<br/>
766<br/>
&#160; L<br/>
<i>malK</i><br/>
&#160; &#160;E,&#160;S<br/>
Methylglucoside(α)-resistant&#160;utilization&#160;of&#160;maltose<br/>
177,&#160;665<br/>
<i>malK</i><br/>
&#160; &#160;E<br/>
Thio(5)maltose&#160;resistance<br/>
223<br/>
&#160; L<br/>
<i>malP</i><br/>
&#160; &#160;E<br/>
Maltose&#160;as&#160;C&#160;source&#160;in&#160;<i>malT</i><br/>
327<br/>
<hr/>
<a name=37></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>malQ</i><br/>
&#160; &#160;E<br/>
Maltose&#160;as&#160;C&#160;source&#160;in&#160;<i>malT</i><br/>
327<br/>
<i>malT</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;resistance<br/>
766<br/>
&#160; L<br/>
<i>malT</i><br/>
&#160; &#160;E<br/>
Thiomaltose&#160;resistance<br/>
223<br/>
&#160; L<br/>
<i>manA</i><br/>
&#160; &#160;E<br/>
Streptozotocin&#160;resistance<br/>
456<br/>
<i>manC</i><br/>
&#160; &#160;E<br/>
Lyxose&#160;(D)&#160;as&#160;C&#160;source<br/>
738<br/>
<i>manXYZ</i><br/>
&#160; &#160;E<br/>
Phage&#160;N4&#160;resistance<br/>
410<br/>
<i>manXYZ</i><br/>
&#160; &#160;E<br/>
Deoxyglucose&#160;resistance<br/>
158,&#160;379<br/>
&#160; L<br/>
<i>marA</i><br/>
&#160; &#160;E<br/>
Menadionine&#160;resistance<br/>
274<br/>
<i>marA</i><br/>
&#160; &#160;E<br/>
Chloramphenicol&#160;resistance<br/>
286<br/>
<i>marA</i><br/>
&#160; &#160;E<br/>
Tetracycline&#160;resistance<br/>
286,&#160;329<br/>
<i>mbrABCD</i><br/>
&#160; &#160;E<br/>
Camphor&#160;resistance<br/>
776,&#160;777<br/>
<i>mdoB</i><br/>
&#160; &#160;E<br/>
Arbutin&#160;resistance&#160;in&#160;<i>dgk</i><br/>
360<br/>
&#160; L<br/>
<i>mel</i>&#160;(generic)<br/>
&#160; &#160;E<br/>
Raffinose&#160;as&#160;C&#160;source&#160;in&#160;<i>lacI</i><br/>
459<br/>
<i>mel</i>&#160;(generic)<br/>
&#160; &#160;S<br/>
Methylglucoside(α)-resistant&#160;utilization&#160;of&#160;melibiose<br/>
665<br/>
<i>melB</i><br/>
&#160; &#160;E<br/>
Deoxy(2)glucose-resistant&#160;utilization&#160;of&#160;melibiose<br/>
431<br/>
&#160; S<br/>
<i>melB</i><br/>
&#160; &#160;E<br/>
Lithium-resistant&#160;utilization&#160;of&#160;melibiose<br/>
397<br/>
&#160; S<br/>
<i>metA</i><br/>
&#160; &#160;S<br/>
Methyl(α)methionine&#160;resistance<br/>
127,&#160;447<br/>
&#160; FBI,&#160;S<br/>
<i>metC</i>&#160;(<i>ecfA</i>?)<br/>
&#160; &#160;E<br/>
Neomycin&#160;resistance<br/>
464<br/>
<i>metC</i>&#160;(<i>ecfA</i>?)<br/>
&#160; &#160;E<br/>
Colicin&#160;K&#160;resistance<br/>
465<br/>
<i>metC</i>&#160;(<i>ecfA</i>?)<br/>
&#160; &#160;E<br/>
Chloro(β)alanine&#160;resistance<br/>
832<br/>
<i>metG</i><br/>
&#160; &#160;E<br/>
Ethionine&#160;resistance<br/>
28<br/>
&#160; S<br/>
<i>metJ</i><br/>
&#160; &#160;E,&#160;S<br/>
Ethionine&#160;resistance<br/>
447<br/>
<i>metJ</i><br/>
&#160; &#160;E<br/>
Glutamyl-γ-methyl&#160;ester&#160;resistance<br/>
425<br/>
&#160; S<br/>
<i>metJ</i><br/>
&#160; &#160;E,&#160;S<br/>
Norleucine&#160;resistance<br/>
128<br/>
<i>metJ</i><br/>
&#160; &#160;E<br/>
Methionine&#160;sulfoximine&#160;+&#160;methyl(α)methionine<br/>
386<br/>
&#160; S<br/>
resistance<br/>
<i>metK</i><br/>
&#160; &#160;E,&#160;S<br/>
Ethionine&#160;resistance<br/>
275,&#160;289,&#160;447,&#160;735<br/>
&#160; S<br/>
<i>metK</i><br/>
&#160; &#160;E<br/>
Glutamyl-γ-methyl&#160;ester&#160;resistance<br/>
425<br/>
&#160; S<br/>
<i>metK</i><br/>
&#160; &#160;E,&#160;S<br/>
Norleucine&#160;resistance<br/>
128,&#160;447,&#160;735<br/>
&#160; S<br/>
<i>metK</i><br/>
&#160; &#160;S<br/>
Methyl(α)methionine&#160;resistance<br/>
447,&#160;735<br/>
&#160; S<br/>
<i>metL</i><br/>
&#160; &#160;E<br/>
Hydroxy&#160;(β)&#160;norvaline&#160;resistance<br/>
138<br/>
&#160; S,&#160;FBI<br/>
<i>metPD</i><br/>
&#160; &#160;E,&#160;S<br/>
Methyl(α)methionine&#160;resistance<br/>
37,&#160;38,&#160;386<br/>
&#160; L<br/>
<i>metPD</i><br/>
&#160; &#160;E,&#160;S<br/>
Methionine&#160;sulfoximine&#160;resistance<br/>
37,&#160;38,&#160;386<br/>
&#160; L<br/>
<i>mglA</i><br/>
&#160; &#160;E<br/>
Fucose&#160;+&#160;arabinose-supported&#160;growth&#160;in&#160;<i>galP</i><br/>
209,&#160;613<br/>
<i>mglB</i><br/>
&#160; &#160;E<br/>
Fucose&#160;+&#160;arabinose-supported&#160;growth&#160;in&#160;<i>galP</i><br/>
209,&#160;613<br/>
<i>mglC</i><br/>
&#160; &#160;E<br/>
Fucose&#160;+&#160;arabinose-supported&#160;growth&#160;in&#160;<i>galP</i><br/>
209,&#160;613<br/>
<i>mglD</i><br/>
&#160; &#160;E<br/>
Methyl-β-galactoside-supported&#160;growth<br/>
645<br/>
&#160; C<br/>
<i>mng</i><br/>
&#160; &#160;E<br/>
Manganese&#160;resistance<br/>
708<br/>
<i>mopA (groEL)</i><br/>
&#160; &#160;E<br/>
T4&#160;phage&#160;resistance<br/>
258<br/>
&#160; S<br/>
<i>mopA(groEL)</i><br/>
&#160; &#160;E<br/>
Lambda&#160;+&#160;434&#160;phage&#160;resistance<br/>
258<br/>
&#160; S<br/>
<i>mopB (groES)</i><br/>
&#160; &#160;E<br/>
T4&#160;phage&#160;resistance<br/>
258<br/>
&#160; S<br/>
<i>mopB (groES)</i><br/>
&#160; &#160;E<br/>
Lambda&#160;+&#160;434&#160;phage&#160;resistance<br/>
258<br/>
&#160; S<br/>
<i>motAB</i><br/>
&#160; &#160;E<br/>
Chi&#160;phage&#160;resistance<br/>
349,&#160;709,&#160;710<br/>
<i>mrb</i><br/>
&#160; &#160;E<br/>
Fosfomycin&#160;resistance<br/>
800<br/>
<i>mrdA</i><br/>
&#160; &#160;E<br/>
Mecillinam&#160;resistance<br/>
759<br/>
<i>mrdB</i><br/>
&#160; &#160;E<br/>
Mecillinam&#160;resistance<br/>
358,&#160;502,&#160;759<br/>
<i>mreBCD</i><br/>
&#160; &#160;E<br/>
Mecillinam&#160;resistance<br/>
582,&#160;807<br/>
<i>mtlA</i><br/>
&#160; &#160;E<br/>
Arabinitol&#160;(D)&#160;resistance<br/>
614<br/>
&#160; L<br/>
<i>mtlC</i><br/>
&#160; &#160;E<br/>
Mannitol&#160;(limiting)&#160;as&#160;C&#160;source<br/>
722<br/>
&#160; C<br/>
<i>mtr</i><br/>
&#160; &#160;E<br/>
Methyl(5)tryptophan&#160;resistance<br/>
305,&#160;320,&#160;523<br/>
&#160; L<br/>
<i>murZ</i><br/>
&#160; &#160;E<br/>
Fosfomycin&#160;resistance&#160;due&#160;to&#160;increased&#160;gene&#160;dosage<br/>
499<br/>
&#160; D<br/>
<hr/>
<a name=38></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>mut</i><br/>
&#160; &#160;E<br/>
Streptomycin&#160;resistance<br/>
309<br/>
(generic)<br/><i>mut</i><br/>
&#160; &#160;E<br/>
Azaserine&#160;resistance<br/>
703<br/>
(generic)<br/><i>mut</i><br/>
&#160; &#160;E<br/>
Chemostat&#160;growth<br/>
152<br/>
(generic)<br/>
<i>mutH</i><br/>
&#160; &#160;E<br/>
Amino(2)purine&#160;resistance&#160;in&#160;<i>dam</i><br/>
267<br/>
&#160; L<br/>
<i>mutL</i><br/>
&#160; &#160;E<br/>
Amino(2)purine&#160;resistance&#160;in&#160;<i>dam</i><br/>
267<br/>
&#160; L<br/>
<i>mutS</i><br/>
&#160; &#160;E<br/>
Amino(2)purine&#160;resistance&#160;in&#160;<i>dam</i><br/>
267<br/>
&#160; L<br/>
<i>mvrC</i><br/>
&#160; &#160;E<br/>
Methyl&#160;viologen&#160;resistance<br/>
532<br/>
&#160; D<br/>
<i>nadB</i><br/>
&#160; &#160;S<br/>
Amino(6)nicotinamide&#160;resistance<br/>
142,&#160;336<br/>
&#160; S<br/>
<i>nadD</i><br/>
&#160; &#160;S<br/>
Amino(6)nicotinamide&#160;resistance<br/>
336,&#160;337<br/>
&#160; L<br/>
<i>nagA</i><br/>
&#160; &#160;E<br/>
Streptozotocin&#160;resistance<br/>
456<br/>
&#160; L<br/>
<i>nagA</i><br/>
&#160; &#160;E<br/>
Iodoacetylglucosamine&#160;resistance<br/>
823<br/>
&#160; L<br/>
<i>nagB</i><br/>
&#160; &#160;E<br/>
Iodoacetylglucosamine&#160;resistance<br/>
823<br/>
&#160; L<br/>
<i>nagE</i><br/>
&#160; &#160;E<br/>
Streptozotocin&#160;resistance<br/>
456<br/>
&#160; L<br/>
<i>nagE</i><br/>
&#160; &#160;E<br/>
Iodoacetylglucosamine&#160;resistance<br/>
823<br/>
&#160; L<br/>
<i>nagE</i><br/>
&#160; &#160;E<br/>
Deoxy(2)-2-iodoacetamideoglucose&#160;resistance<br/>
379<br/>
&#160; L<br/>
<i>nalB</i><br/>
&#160; &#160;E<br/>
Nalidixic&#160;acid&#160;resistance<br/>
298<br/>
<i>nalD</i><br/>
&#160; &#160;E<br/>
Nalidixic&#160;acid&#160;resistance<br/>
333<br/>
<i>nar</i>&#160;(general)<br/>
&#160; &#160;E<br/>
Metronidazole&#160;resistance<br/>
677<br/>
&#160; L<br/>
<i>narC</i><br/>
&#160; &#160;E<br/>
Chlorate&#160;resistance<br/>
266,&#160;280<br/>
&#160; L<br/>
<i>narG</i><br/>
&#160; &#160;E<br/>
Chlorate&#160;resistance<br/>
739<br/>
&#160; L<br/>
<i>narH</i><br/>
&#160; &#160;E<br/>
Chlorate&#160;resistance<br/>
739<br/>
&#160; L<br/>
<i>ndk</i><br/>
&#160; &#160;S<br/>
Aza(8)guanine&#160;resistance<br/>
264,&#160;650<br/>
<i>neaB</i><br/>
&#160; &#160;E,&#160;S<br/>
Neamine&#160;resistance<br/>
119,&#160;182,&#160;495<br/>
<i>nek</i><br/>
&#160; &#160;E<br/>
Aminoglycoside&#160;resistance<br/>
27,&#160;342<br/>
<i>nfnA</i><br/>
&#160; &#160;E<br/>
Nitrofurantoin&#160;resistance<br/>
684<br/>
<i>nfnB</i><br/>
&#160; &#160;E<br/>
Nitrofurantoin&#160;resistance<br/>
684<br/>
<i>nfsA</i><br/>
&#160; &#160;E<br/>
Nitrofuranzone&#160;resistance<br/>
90,&#160;505<br/>
<i>nfsB</i><br/>
&#160; &#160;E<br/>
Nitrofuranzone&#160;resistance<br/>
90,&#160;505<br/>
<i>nhaA</i><br/>
&#160; &#160;E<br/>
Lithium&#160;resistance&#160;(multicopy)<br/>
628<br/>
&#160; D<br/>
<i>nol</i><br/>
&#160; &#160;S<br/>
Norleucine&#160;resistance<br/>
324<br/>
<i>nov</i><br/>
&#160; &#160;E<br/>
Novobiocin&#160;resistance<br/>
630<br/>
<i>nrdA</i><br/>
&#160; &#160;E<br/>
Hydroxyurea&#160;resistance<br/>
609<br/>
&#160; D<br/>
<i>nrdB</i><br/>
&#160; &#160;E<br/>
Hydroxyurea&#160;resistance<br/>
609<br/>
&#160; D<br/>
<i>nupC</i><br/>
&#160; &#160;E<br/>
Showdomycin&#160;resistance<br/>
415,&#160;545<br/>
&#160; L<br/>
<i>nupC</i><br/>
&#160; &#160;E<br/>
Fluorouracil&#160;resistance<br/>
544<br/>
&#160; L<br/>
<i>nupC</i><br/>
&#160; &#160;E<br/>
Fluorodeoxyuridine&#160;resistance<br/>
545<br/>
&#160; L<br/>
<i>nupC</i><br/>
&#160; &#160;E<br/>
Fluoruridine&#160;resistance<br/>
544<br/>
&#160; L<br/>
<i>nupC</i><br/>
&#160; &#160;E<br/>
Fluorodeoxycytidine&#160;resistance<br/>
544<br/>
&#160; L<br/>
<i>nupG</i><br/>
&#160; &#160;E<br/>
Fluorouracil&#160;resistance<br/>
544<br/>
&#160; L<br/>
<i>nupG</i><br/>
&#160; &#160;E<br/>
Fluorodeoxyuridine&#160;resistance<br/>
545<br/>
&#160; L<br/>
<i>nupG</i><br/>
&#160; &#160;E<br/>
Fluorouridine&#160;resistance<br/>
544<br/>
&#160; L<br/>
<i>nupG</i><br/>
&#160; &#160;E<br/>
Fluorodeoxycytidine&#160;resistance<br/>
544<br/>
&#160; L<br/>
<i>nusA</i><br/>
&#160; &#160;E<br/>
Lambda&#160;prophage&#160;induction,&#160;survival&#160;of<br/>
244<br/>
<i>nusB</i><br/>
&#160; &#160;E<br/>
Lambda&#160;prophage&#160;induction,&#160;survival&#160;of<br/>
245,&#160;260<br/>
<i>nusB</i><br/>
&#160; &#160;E<br/>
Lambdoid&#160;phage&#160;resistance<br/>
260<br/>
<i>nuvA</i><br/>
&#160; &#160;E,&#160;S<br/>
Near-UV&#160;irradiation&#160;resistance<br/>
424,&#160;468,&#160;767<br/>
&#160; L<br/>
<i>nuvC</i><br/>
&#160; &#160;E<br/>
Near-UV&#160;irradiation&#160;resistance<br/>
663<br/>
<i>ompA</i><br/>
&#160; &#160;E<br/>
K3&#160;phage&#160;resistance<br/>
306,&#160;489,&#160;491,&#160;493<br/>
&#160; L<br/>
<i>ompA</i><br/>
&#160; &#160;E<br/>
T-even-like&#160;phage&#160;resistance<br/>
199,&#160;533,&#160;535<br/>
&#160; S<br/>
<i>ompA</i><br/>
&#160; &#160;E<br/>
TuII*&#160;phage&#160;resistance<br/>
171,&#160;314,&#160;493<br/>
&#160; L<br/>
<i>ompA</i><br/>
&#160; &#160;E<br/>
Ox2&#160;phage&#160;resistance<br/>
199,&#160;493,&#160;642<br/>
<i>ompA</i><br/>
&#160; &#160;E<br/>
Bacteriocin&#160;JF246&#160;resistance<br/>
124,&#160;491<br/>
<i>ompA</i><br/>
&#160; &#160;S<br/>
Bacteriocin&#160;4-59&#160;resistance<br/>
741<br/>
&#160; L<br/>
<i>ompA</i><br/>
&#160; &#160;E<br/>
Colicin&#160;K&#160;tolerance<br/>
491<br/>
<i>ompA</i><br/>
&#160; &#160;E<br/>
Colicin&#160;L&#160;tolerance<br/>
491<br/>
<i>ompA</i><br/>
&#160; &#160;E<br/>
Chelator&#160;resistance<br/>
493<br/>
<i>ompA</i><br/>
&#160; &#160;E<br/>
Novobiocin&#160;resistance<br/>
493<br/>
<hr/>
<a name=39></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>ompB</i><br/>
&#160; &#160;S<br/>
PH51&#160;phage&#160;resistance<br/>
372<br/>
<i>ompB</i><br/>
&#160; &#160;S<br/>
PH105&#160;phage&#160;resistance<br/>
372<br/>
<i>ompC</i><br/>
&#160; &#160;E<br/>
Me1&#160;phage&#160;resistance<br/>
791,&#160;801<br/>
&#160; L<br/>
<i>ompC</i><br/>
&#160; &#160;E<br/>
TuIa&#160;phage&#160;resistance<br/>
801<br/>
&#160; L<br/>
<i>ompC</i><br/>
&#160; &#160;S<br/>
PH51&#160;phage&#160;resistance<br/>
372<br/>
&#160; L<br/>
<i>ompC</i><br/>
&#160; &#160;S<br/>
PH105&#160;phage&#160;resistance<br/>
372<br/>
&#160; L<br/>
<i>ompC</i><br/>
&#160; &#160;E<br/>
Host&#160;range&#160;<i>Serratia&#160;marcescens</i>&#160;phage&#160;resistance<br/>
702<br/>
<i>ompD</i><br/>
&#160; &#160;S<br/>
PH51&#160;phage&#160;resistance<br/>
741<br/>
&#160; L<br/>
<i>ompD</i><br/>
&#160; &#160;S<br/>
Bacteriocin&#160;4-59&#160;resistance<br/>
741<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Beta-lactam&#160;(ampicillin,&#160;cefoxitin)&#160;resistance<br/>
362,&#160;363<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Chloramphenicol&#160;resistance<br/>
235,&#160;523<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Tetracycline&#160;resistance<br/>
235,&#160;523<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Fluoro(5)uracil&#160;+&#160;nucleotide&#160;resistance<br/>
52<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Colicin&#160;A&#160;tolerance<br/>
125,&#160;235<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Cloacin&#160;DF13&#160;resistance<br/>
846<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Colicin&#160;L&#160;tolerance<br/>
235,&#160;291<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Colicin&#160;K&#160;tolerance<br/>
235<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Colicin&#160;E2&#160;tolerance<br/>
235<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Colicin&#160;E3&#160;tolerance<br/>
235<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Me1&#160;phage&#160;resistance<br/>
801<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
TuIa&#160;phage&#160;resistance<br/>
801<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
TuIb&#160;phage&#160;resistance<br/>
237<br/>
<i>ompF</i><br/>
&#160; &#160;S<br/>
PH51&#160;phage&#160;resistance<br/>
372<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;S<br/>
PH105&#160;phage&#160;resistance<br/>
372<br/>
&#160; L<br/>
<i>ompF</i><br/>
&#160; &#160;E<br/>
Copper&#160;resistance&#160;in&#160;<i>ompC</i><br/>
480<br/>
<i>ompR</i><br/>
&#160; &#160;E<br/>
Me1&#160;phage&#160;resistance<br/>
801<br/>
<i>ompR</i><br/>
&#160; &#160;E<br/>
TuIa&#160;phage&#160;resistance<br/>
801<br/>
<i>ompR</i><br/>
&#160; &#160;E<br/>
Copper&#160;resistance<br/>
52,&#160;625<br/>
<i>ompR</i><br/>
&#160; &#160;E<br/>
Beta-lactam&#160;(ampicillin,&#160;cefoxitin)&#160;resistance<br/>
362,&#160;363<br/>
&#160; L<br/>
<i>ompR</i><br/>
&#160; &#160;E<br/>
Chloramphenicol&#160;resistance<br/>
625<br/>
<i>ompR</i><br/>
&#160; &#160;E<br/>
Fluoro(5)uracil&#160;+&#160;nucleotide&#160;resistance<br/>
52<br/>
<i>oppA</i><br/>
&#160; &#160;E,&#160;S<br/>
Triornithine&#160;resistance<br/>
43,&#160;317<br/>
&#160; L<br/>
<i>oppA</i><br/>
&#160; &#160;E<br/>
Glycylleucine&#160;resistance<br/>
806<br/>
&#160; L<br/>
<i>oppA</i><br/>
&#160; &#160;E<br/>
Alanyl-2-aminopropionate&#160;resistance<br/>
603<br/>
&#160; L<br/>
<i>oppA</i><br/>
&#160; &#160;E,&#160;S<br/>
Trilysine&#160;resistance<br/>
317<br/>
&#160; L<br/>
<i>oppA</i><br/>
&#160; &#160;E,&#160;S<br/>
Norleucylglycyl&#160;glycine&#160;resistance<br/>
317<br/>
&#160; L<br/>
<i>oppA</i><br/>
&#160; &#160;S<br/>
Glycylglycyl&#160;histidinol&#160;phosphate&#160;ester&#160;resistance<br/>
317<br/>
&#160; L<br/>
<i>oppA</i><br/>
&#160; &#160;E,&#160;S<br/>
Phaseolotoxin&#160;resistance<br/>
733<br/>
&#160; L<br/>
<i>oppA</i><br/>
&#160; &#160;E<br/>
Tripeptide&#160;(toxic&#160;amino&#160;acid&#160;containing)&#160;resistance<br/>
604<br/>
&#160; L<br/>
<i>oppA</i><br/>
&#160; &#160;E<br/>
Glycylglycyl-<i>N</i>-<i>S</i>-(phosphonoacetyl)-L-ornithine<br/>
604<br/>
&#160; L<br/>
resistance<br/>
<i>oppE</i><br/>
&#160; &#160;E<br/>
Tripeptide&#160;(toxic&#160;amino&#160;acid&#160;containing)&#160;resistance<br/>
22<br/>
&#160; L<br/>
<i>optA</i><br/>
&#160; &#160;E<br/>
T7&#160;phage&#160;gene&#160;1.2&#160;mutant&#160;resistance<br/>
666<br/>
<i>osmB</i><br/>
&#160; &#160;E<br/>
Osmotolerance<br/>
384<br/>
&#160; L<br/>
<i>osmZ</i><br/>
&#160; &#160;E<br/>
Arbutin&#160;as&#160;C&#160;source<br/>
179<br/>
<i>osmZ</i><br/>
&#160; &#160;E<br/>
Salicin&#160;as&#160;C&#160;source<br/>
179<br/>
<i>oxyR</i><br/>
&#160; &#160;E,&#160;S<br/>
Peroxide&#160;resistance<br/>
131<br/>
&#160; C<br/>
<i>pab</i><br/>
&#160; &#160;E<br/>
Sulfonamide&#160;resistance<br/>
97<br/>
&#160; C<br/>
<i>pan</i><br/>
&#160; &#160;E<br/>
Salicylate&#160;resistance<br/>
481<br/>
&#160; C<br/>
<i>pan</i><br/>
&#160; &#160;E<br/>
Hydroxyaspartate&#160;resistance<br/>
701<br/>
&#160; C<br/>
<i>pan</i><br/>
&#160; &#160;E<br/>
Pentylpantothenamide&#160;resistance<br/>
136<br/>
&#160; C<br/>
<i>pdx</i><br/>
&#160; &#160;E<br/>
Isoniazid&#160;resistance<br/>
186<br/>
&#160; C<br/>
<i>pepA</i><br/>
&#160; &#160;S<br/>
Alafosfalin&#160;resistance<br/>
263<br/>
&#160; L<br/>
<i>pepA</i><br/>
&#160; &#160;E,&#160;S<br/>
Peptide&#160;(toxic,&#160;valine&#160;containing)&#160;resistance&#160;in&#160;<i>pepN</i><br/>
517<br/>
&#160; L<br/>
<i>pepD</i><br/>
&#160; &#160;E,&#160;S<br/>
Peptide&#160;(toxic,&#160;valine&#160;containing)&#160;resistance&#160;in&#160;<i>pepN</i><br/>
517<br/>
&#160; L<br/>
<i>pepA</i><br/>
<i>pepN</i><br/>
&#160; &#160;E,&#160;S<br/>
Albomycin&#160;resistance<br/>
86<br/>
&#160; L<br/>
<i>pepN</i><br/>
&#160; &#160;E,&#160;S<br/>
Peptide&#160;(toxic,&#160;valine&#160;containing)&#160;resistance<br/>
517<br/>
&#160; L<br/>
<i>pepN</i><br/>
&#160; &#160;E,&#160;S<br/>
Indicator&#160;plate<br/>
445<br/>
<hr/>
<a name=40></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>pepQ</i><br/>
&#160; &#160;E,&#160;S<br/>
Peptide&#160;(toxic,&#160;valine&#160;containing)&#160;resistance<br/>
517<br/>
&#160; L<br/>
<i>pfkA</i><br/>
&#160; &#160;E<br/>
Streptozotocin&#160;resistance<br/>
456<br/>
&#160; L<br/>
<i>pgi</i><br/>
&#160; &#160;E<br/>
U3&#160;phage&#160;resistance<br/>
816<br/>
&#160; L<br/>
<i>pgi</i><br/>
&#160; &#160;E<br/>
Fosfomycin&#160;+&#160;fructose-6-phosphate&#160;resistance<br/>
243<br/>
&#160; L<br/>
<i>pgm</i><br/>
&#160; &#160;E<br/>
U3&#160;phage&#160;resistance<br/>
816<br/>
&#160; L<br/>
<i>pheA</i><br/>
&#160; &#160;E<br/>
Fluoro(4)phenylalanine&#160;resistance<br/>
351,&#160;564<br/>
&#160; C,&#160;FBI<br/>
<i>pheR</i><br/>
&#160; &#160;S<br/>
Fluoro(4)phenylalanine&#160;resistance<br/>
271<br/>
&#160; C<br/>
<i>pheS</i><br/>
&#160; &#160;E<br/>
Fluoro(4)phenylalanine&#160;resistance<br/>
78,&#160;218,&#160;395<br/>
&#160; S<br/>
<i>pheS</i><br/>
&#160; &#160;E<br/>
Thymineless&#160;death&#160;resistance&#160;in&#160;<i>thyA</i><br/>
394<br/>
&#160; S<br/>
<i>pheU</i><br/>
&#160; &#160;S<br/>
Fluoro(4)phenylalanine&#160;resistance<br/>
729<br/>
<i>pho</i><br/>
&#160; &#160;S<br/>
Glycerol(β)-phosphate&#160;as&#160;C&#160;source&#160;in&#160;the&#160;presence&#160;of<br/>
407<br/>
&#160; C<br/>
high&#160;phosphate<br/>
<i>phoA</i><br/>
&#160; &#160;E<br/>
Fluoro(5)uracil&#160;+&#160;adenosine&#160;resistance&#160;in&#160;<i>upp,&#160;phoS,</i>&#160;or<br/>
315<br/>
<i>phoT</i><br/>
<i>phoA</i><br/>
&#160; &#160;E<br/>
Glycerol(β)-phosphate&#160;as&#160;C&#160;source&#160;in&#160;the&#160;presence&#160;of<br/>
773<br/>
&#160; C<br/>
high&#160;phosphate<br/>
<i>phoA</i><br/>
&#160; &#160;E<br/>
Glycerol(β)-phosphate&#160;resistance&#160;in&#160;<i>glpD</i><br/>
678<br/>
<i>phoB</i><br/>
&#160; &#160;E<br/>
Tellurite&#160;resistance<br/>
770<br/>
<i>phoB</i><br/>
&#160; &#160;E<br/>
TC45&#160;phage&#160;resistance<br/>
771<br/>
&#160; L<br/>
<i>phoB</i><br/>
&#160; &#160;E<br/>
Fluoro(5)uracil&#160;+&#160;adenosine&#160;resistance&#160;in&#160;<i>upp,&#160;phoS,</i>&#160;or<br/>
316<br/>
<i>phoT</i><br/>
<i>phoE</i><br/>
&#160; &#160;E<br/>
Acid&#160;resistance<br/>
659<br/>
&#160; D<br/>
<i>phoE</i><br/>
&#160; &#160;E<br/>
TC45&#160;phage&#160;resistance<br/>
420,&#160;771<br/>
&#160; S,&#160;L<br/>
<i>phoR</i><br/>
&#160; &#160;E<br/>
Arsenate&#160;resistance<br/>
852<br/>
<i>phoR</i><br/>
&#160; &#160;E<br/>
Glycerol(β)-phosphate&#160;as&#160;C&#160;source&#160;in&#160;the&#160;presence&#160;of<br/>
204,&#160;838<br/>
high&#160;phosphate<br/>
<i>phoR</i><br/>
&#160; &#160;E<br/>
TC45&#160;phage&#160;resistance<br/>
621<br/>
&#160; S<br/>
<i>phoS</i><br/>
&#160; &#160;E<br/>
Arsenate&#160;resistance<br/>
852<br/>
<i>phoS</i><br/>
&#160; &#160;E<br/>
Glycerol(β)-phosphate&#160;as&#160;C&#160;source&#160;in&#160;the&#160;presence&#160;of<br/>
204,&#160;838<br/>
high&#160;phosphate<br/>
<i>phoS</i><br/>
&#160; &#160;E<br/>
TC45&#160;phage&#160;resistance<br/>
621<br/>
&#160; S<br/>
<i>phoT</i><br/>
&#160; &#160;E<br/>
Arsenate&#160;resistance<br/>
852<br/>
<i>phoT</i><br/>
&#160; &#160;E<br/>
Glycerol(β)-phosphate&#160;as&#160;C&#160;source&#160;in&#160;the&#160;presence&#160;of<br/>
204,&#160;838<br/>
high&#160;phosphate<br/>
<i>phoT</i><br/>
&#160; &#160;E<br/>
TC45&#160;phage&#160;resistance<br/>
621<br/>
&#160; S<br/>
<i>phr</i><br/>
&#160; &#160;E<br/>
T1&#160;phage&#160;(UV&#160;irradiated)&#160;resistance<br/>
332<br/>
&#160; L<br/>
<i>phxB</i><br/>
&#160; &#160;E<br/>
φX174&#160;phage&#160;resistance<br/>
547<br/>
&#160; L<br/>
<i>pit</i><br/>
&#160; &#160;E<br/>
Arsenate&#160;resistance<br/>
59,&#160;727<br/>
&#160; L<br/>
<i>pldA</i><br/>
&#160; &#160;E<br/>
Actinomycin&#160;D&#160;resistance&#160;in&#160;the&#160;presence&#160;of&#160;EDTA<br/>
301,&#160;805<br/>
&#160; L<br/>
<i>pmi</i><br/>
&#160; &#160;S<br/>
P22&#160;phage&#160;resistance<br/>
656,&#160;833<br/>
&#160; L<br/>
<i>pmi</i><br/>
&#160; &#160;S<br/>
9NA&#160;phage&#160;resistance<br/>
656,&#160;833<br/>
&#160; L<br/>
<i>pmrA</i><br/>
&#160; &#160;E,&#160;S<br/>
Polymyxin&#160;resistance<br/>
219,&#160;297,&#160;485,<br/>785–788<br/>
<i>pmrA</i><br/>
&#160; &#160;S<br/>
Neutrophil&#160;granule&#160;protein&#160;resistance<br/>
219<br/>
<i>pncA</i><br/>
&#160; &#160;E,&#160;S<br/>
Amino(6)nicotinamide&#160;resistance<br/>
234,&#160;455,&#160;822<br/>
&#160; L<br/>
<i>pncA</i><br/>
&#160; &#160;E<br/>
Nicotinamide&#160;as&#160;sole&#160;N source<br/>
598<br/>
&#160; Q<br/>
<i>pncB</i><br/>
&#160; &#160;E,&#160;S<br/>
Amino(6)nicotinamide&#160;resistance<br/>
234,&#160;455<br/>
&#160; L<br/>
<i>pncB</i><br/>
&#160; &#160;E,&#160;S<br/>
Amino(6)nicotinate&#160;resistance<br/>
234,&#160;455<br/>
&#160; L<br/>
<i>pncX</i><br/>
&#160; &#160;S<br/>
Amino(6)nicotinamide&#160;resistance<br/>
336<br/>
<i>pnp</i><br/>
&#160; &#160;E<br/>
Showdomycin&#160;resistance<br/>
58<br/>
<i>polA</i><br/>
&#160; &#160;E<br/>
Lambda&#160;γ&#160;mutant&#160;phage&#160;resistance<br/>
867<br/>
&#160; L<br/>
<i>praA,B</i><br/>
&#160; &#160;S<br/>
P221&#160;phage&#160;resistance<br/>
576,&#160;674<br/>
&#160; L<br/>
<i>praA,B</i><br/>
&#160; &#160;S<br/>
PH51&#160;phage&#160;resistance<br/>
576<br/>
&#160; L<br/>
<i>praA,B</i><br/>
&#160; &#160;S<br/>
PH105&#160;phage&#160;resistance<br/>
576<br/>
&#160; L<br/>
<i>prbA,B</i><br/>
&#160; &#160;S<br/>
ES18&#160;phage&#160;resistance<br/>
674<br/>
<hr/>
<a name=41></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>prdB</i><br/>
&#160; &#160;S<br/>
PH51&#160;phage&#160;resistance<br/>
674<br/>
<i>prfA</i><br/>
&#160; &#160;E<br/>
Phenylgalactoside&#160;resistance&#160;of&#160;<i>lacP&#160;lacI</i>(nonsense)<br/>
747<br/>
<i>supE</i><br/>
<i>prfB</i><br/>
&#160; &#160;E<br/>
Negamycin&#160;resistance<br/>
145<br/>
<i>prh</i><br/>
&#160; &#160;S<br/>
HK009&#160;phage&#160;resistance<br/>
674<br/>
<i>prk</i><br/>
&#160; &#160;S<br/>
HK068&#160;phage&#160;resistance<br/>
674<br/>
<i>proAB</i><br/>
&#160; &#160;S<br/>
Osmotolerance<br/>
155<br/>
<i>proA</i><br/>
&#160; &#160;E<br/>
Nitro(4)pyridine&#160;<i>N</i>-oxide&#160;resistance<br/>
62,&#160;222,&#160;321<br/>
&#160; L<br/>
<i>proB</i><br/>
&#160; &#160;E,&#160;S<br/>
Dehydroproline&#160;resistance<br/>
62,&#160;155,&#160;635<br/>
&#160; FBI,&#160;S<br/>
<i>proB</i><br/>
&#160; &#160;E<br/>
Nitro(4)pyridine&#160;<i>N</i>-oxide&#160;resistance<br/>
62,&#160;222,&#160;321<br/>
<i>proB</i><br/>
&#160; &#160;E,&#160;S<br/>
Azetidine&#160;carboxylate&#160;resistance<br/>
62,&#160;155,&#160;635<br/>
&#160; FBI,&#160;S<br/>
<i>proP</i><br/>
&#160; &#160;E,&#160;S<br/>
Dehydroproline&#160;resistance&#160;in&#160;<i>putA&#160;putP</i><br/>
156,&#160;732<br/>
&#160; L<br/>
<i>proU</i><br/>
&#160; &#160;S<br/>
Dehydroproline&#160;+&#160;azetidine&#160;carboxylate&#160;resistance&#160;at<br/>
156<br/>
&#160; L<br/>
high&#160;osmolarity&#160;in&#160;<i>putA&#160;putP</i><br/>
<i>prp</i><br/>
&#160; &#160;E<br/>
Propionate&#160;as&#160;C&#160;source<br/>
400<br/>
&#160; Q<br/>
<i>pspABCDE</i><br/>
&#160; &#160;E<br/>
Sulfanilamide&#160;+&#160;hypoxanthine&#160;resistance<br/>
97<br/>
<i>pss</i><br/>
&#160; &#160;E<br/>
Ethanol&#160;resistance<br/>
133<br/>
<i>pss</i><br/>
&#160; &#160;E<br/>
Dimethyl&#160;sulfoxide&#160;resistance<br/>
133<br/>
<i>pstABCS</i><br/>
&#160; &#160;E<br/>
Arsenate&#160;resistance<br/>
727,&#160;838<br/>
&#160; L<br/>
<i>pstABCS</i><br/>
&#160; &#160;E<br/>
TC45&#160;phage&#160;resistance<br/>
621<br/>
&#160; S<br/>
<i>pta</i><br/>
&#160; &#160;S<br/>
Fluoroacetate&#160;resistance<br/>
96,&#160;281,&#160;463,&#160;797<br/>
<i>pts</i>&#160;(general)<br/>
&#160; &#160;E<br/>
Glucose&#160;+&#160;gluconate-independent&#160;motility<br/>
30<br/>
<i>ptsG</i><br/>
&#160; &#160;E<br/>
Methyl(α)-glucoside&#160;resistance<br/>
102,&#160;104<br/>
<i>ptsG</i><br/>
&#160; &#160;E<br/>
Sorbose&#160;resistance<br/>
715<br/>
&#160; L<br/>
<i>ptsG</i><br/>
&#160; &#160;E,&#160;S<br/>
Deoxy(2)glucose-independent&#160;utilization&#160;of&#160;fructose<br/>
418,&#160;510<br/>
&#160; L<br/>
<i>ptsG</i><br/>
&#160; &#160;E,&#160;S<br/>
Deoxy(3)-3-fluoroglucose-independent&#160;utilization&#160;of<br/>
418,&#160;510<br/>
&#160; L<br/>
fructose<br/>
<i>ptsG</i><br/>
&#160; &#160;E<br/>
Methyl(α)-glucoside-independent&#160;lactose&#160;+&#160;mannitol<br/>
80<br/>
&#160; L<br/>
utilization<br/>
<i>ptsG</i><br/>
&#160; &#160;E<br/>
Glucosamine&#160;as&#160;C&#160;source<br/>
379<br/>
<i>ptsG</i><br/>
&#160; &#160;E<br/>
Mannose&#160;as&#160;C&#160;source<br/>
379<br/>
<i>ptsHI</i><br/>
&#160; &#160;E,&#160;S<br/>
Deoxy(3)-3-fluoroglucose-independent&#160;utilization&#160;of<br/>
510<br/>
&#160; L<br/>
lactate<br/>
<i>ptsHI</i><br/>
&#160; &#160;E,&#160;S<br/>
Fosfomycin&#160;resistance<br/>
146,&#160;800<br/>
&#160; L<br/>
<i>ptsHI</i><br/>
&#160; &#160;E<br/>
Streptozotocin&#160;resistance<br/>
16;&#160;Freitag<i>h</i><br/>
&#160; L<br/>
<i>ptsI</i><br/>
&#160; &#160;E<br/>
Ampicillin&#160;resistance<br/>
212<br/>
<i>ptsI</i><br/>
&#160; &#160;S<br/>
Deoxy(3)-3-fluoroglucose&#160;resistance<br/>
510<br/>
&#160; L<br/>
<i>purA</i><br/>
&#160; &#160;E<br/>
Methyl(6)purine&#160;+&#160;hypoxanthine&#160;resistance<br/>
60<br/>
<i>purB</i><br/>
&#160; &#160;E<br/>
Nalidixic&#160;acid&#160;resistance<br/>
310<br/>
&#160; L<br/>
<i>purR</i><br/>
&#160; &#160;E<br/>
Adenine&#160;resistance&#160;in&#160;<i>hpt&#160;gpt</i><br/>
461,&#160;462<br/>
<i>putA</i><br/>
&#160; &#160;E,&#160;S<br/>
Azetidine&#160;carboxylic&#160;acid&#160;resistance<br/>
511,&#160;635,&#160;775<br/>
&#160; L<br/>
<i>putAP</i><br/>
&#160; &#160;S<br/>
Baikiain&#160;resistance&#160;in&#160;constitutive&#160;background<br/>
187<br/>
&#160; L<br/>
<i>putA</i><br/>
&#160; &#160;S<br/>
Proline&#160;as&#160;N&#160;source&#160;with&#160;glucose&#160;as&#160;C&#160;source<br/>
566<br/>
<i>putP</i><br/>
&#160; &#160;E,&#160;S<br/>
Dehydroproline&#160;resistance<br/>
193,&#160;511,&#160;635,&#160;732,<br/>
&#160; L<br/>
775,&#160;843<br/>
<i>putP</i><br/>
&#160; &#160;E,&#160;S<br/>
Azetidine&#160;carboxylic&#160;acid&#160;resistance<br/>
193,&#160;511,&#160;635,&#160;775,<br/>
&#160; L<br/>
843<br/>
<i>putP</i><br/>
&#160; &#160;S<br/>
Lithium-resistant&#160;proline&#160;utilization&#160;as&#160;C&#160;source<br/>
551<br/>
&#160; S<br/>
<i>puvA</i><br/>
&#160; &#160;E<br/>
Psoralen&#160;+&#160;UV&#160;irradiation&#160;resistance<br/>
328<br/>
&#160; C<br/>
<i>pyrB</i><br/>
&#160; &#160;S<br/>
Arginine-independent&#160;growth&#160;of&#160;<i>pyrH</i>&#160;in&#160;the&#160;presence<br/>
366<br/>
&#160; L<br/>
of&#160;uracil<br/>
<i>pyrC</i><br/>
&#160; &#160;S<br/>
Arginine-independent&#160;growth&#160;of&#160;<i>pyrH</i>&#160;in&#160;the&#160;presence<br/>
366<br/>
&#160; L<br/>
of&#160;uracil<br/>
<i>pyrD</i><br/>
&#160; &#160;S<br/>
Arginine-independent&#160;growth&#160;of&#160;<i>pyrH</i>&#160;in&#160;the&#160;presence<br/>
366<br/>
&#160; L<br/>
of&#160;uracil<br/>
<i>pyrF</i><br/>
&#160; &#160;E<br/>
Fluoro(5)orotic&#160;acid&#160;resistance<br/>
74<br/>
&#160; L<br/>
<i>pyrH</i><br/>
&#160; &#160;S<br/>
Fluoro(5)orotic&#160;acid&#160;resistance<br/>
865<br/>
&#160; C<br/>
<i>pyrH</i><br/>
&#160; &#160;S<br/>
Fluorouracil&#160;resistance<br/>
385<br/>
&#160; C<br/>
<i>pyrH</i><br/>
&#160; &#160;S<br/>
Fluorouridine&#160;resistance<br/>
385<br/>
&#160; C<br/>
<hr/>
<a name=42></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>pyrH</i><br/>
&#160; &#160;E<br/>
Fluoro(5)uracil&#160;+&#160;5-fluorouridine&#160;resistance&#160;in&#160;<i>udp</i><br/>
606<br/>
<i>qmeACDE</i><br/>
&#160; &#160;E<br/>
Glycine&#160;tolerance<br/>
829<br/>
<i>rap</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;resistance<br/>
279<br/>
<i>recA</i><br/>
&#160; &#160;E<br/>
Lambda&#160;prophage&#160;induction&#160;deficiency&#160;during&#160;thymine<br/>
190<br/>
deprivation<br/>
<i>recF</i><br/>
&#160; &#160;E<br/>
Thymineless&#160;death&#160;resistance&#160;in&#160;<i>thyA</i><br/>
558<br/>
<i>recJ</i><br/>
&#160; &#160;E<br/>
Thymineless&#160;death&#160;resistance&#160;in&#160;<i>thyA</i><br/>
558<br/>
<i>recO</i><br/>
&#160; &#160;E<br/>
Thymineless&#160;death&#160;resistance&#160;in&#160;<i>thyA</i><br/>
558<br/>
<i>recQ</i><br/>
&#160; &#160;E<br/>
Thymineless&#160;death&#160;resistance&#160;in&#160;<i>thyA</i><br/>
557<br/>
<i>relA</i><br/>
&#160; &#160;E<br/>
UV&#160;(near)&#160;irradiation&#160;resistance<br/>
632<br/>
&#160; L<br/>
<i>relA</i><br/>
&#160; &#160;E<br/>
Serine&#160;resistance&#160;in&#160;<i>relA</i><br/>
167<br/>
<i>rep</i><br/>
&#160; &#160;E<br/>
P2&#160;phage&#160;resistance<br/>
113<br/>
<i>rfa</i>&#160;(general)<br/>
&#160; &#160;E,&#160;S<br/>
U3&#160;and&#160;FO&#160;phage&#160;resistance<br/>
35,&#160;484,&#160;486,&#160;588,<br/>833<br/>
<i>rfa</i>&#160;(general)<br/>
&#160; &#160;E,&#160;S<br/>
Ampicillin&#160;resistance<br/>
212,&#160;550,&#160;562<br/>
<i>rfa</i>&#160;(general)<br/>
&#160; &#160;S<br/>
Hemin&#160;satisfaction&#160;of&#160;<i>hemA</i>&#160;auxotrophy<br/>
364<br/>
<i>rfa</i>&#160;(general)<br/>
&#160; &#160;S<br/>
Cephalothin&#160;resistance<br/>
562<br/>
<i>rfa</i>&#160;(general)<br/>
&#160; &#160;S<br/>
Bacitracin&#160;resistance<br/>
562<br/>
<i>rfaCDEF</i><br/>
&#160; &#160;S<br/>
FO&#160;phage&#160;resistance<br/>
676<br/>
<i>rfaD</i><br/>
&#160; &#160;E<br/>
C21&#160;phage&#160;resistance<br/>
141<br/>
<i>rfaD</i><br/>
&#160; &#160;E<br/>
P1&#160;phage&#160;resistance<br/>
141<br/>
<i>rfaH</i><br/>
&#160; &#160;S<br/>
FO&#160;phage&#160;resistance<br/>
458,&#160;675<br/>
<i>rfaP</i><br/>
&#160; &#160;E<br/>
U3&#160;phage&#160;+&#160;K3&#160;phage&#160;coresistance<br/>
601<br/>
<i>rfb</i><br/>
&#160; &#160;S<br/>
DCCD&#160;resistance&#160;in&#160;<i>rfa</i><br/>
833<br/>
<i>rho</i><br/>
&#160; &#160;E<br/>
T4&#160;phage&#160;resistance<br/>
740<br/>
<i>rho</i><br/>
&#160; &#160;E<br/>
Lambda&#160;<i>sus&#160;N7&#160;nin-5</i>&#160;resistance&#160;in&#160;P2&#160;lysogen<br/>
352,&#160;353<br/>
<i>rho</i><br/>
&#160; &#160;E,&#160;S<br/>
Polarity&#160;suppression&#160;of&#160;<i>gal</i>&#160;leader&#160;insertion<br/>
169,&#160;331<br/>
<i>ridA</i><br/>
&#160; &#160;E<br/>
Rifampin&#160;+&#160;kasugamycin&#160;dependence<br/>
162<br/>
<i>ridB</i><br/>
&#160; &#160;E<br/>
Rifampin&#160;dependence<br/>
160<br/>
<i>rplC</i><br/>
&#160; &#160;E<br/>
Tiamulin&#160;resistance<br/>
73<br/>
<i>rplD</i><br/>
&#160; &#160;E<br/>
Erythromycin&#160;resistance<br/>
725,&#160;840<br/>
&#160; S<br/>
<i>rplE</i><br/>
&#160; &#160;E<br/>
Thiopeptin&#160;resistance<br/>
467<br/>
<i>rplF</i><br/>
&#160; &#160;E<br/>
Gentamicin&#160;resistance<br/>
101<br/>
&#160; S<br/>
<i>rplK</i><br/>
&#160; &#160;E<br/>
Kasugamycin&#160;resistance<br/>
159<br/>
<i>rplK</i><br/>
&#160; &#160;E<br/>
DAP&#160;starvation&#160;of&#160;∆(<i>mal-asd</i>)&#160;in&#160;the&#160;presence&#160;of&#160;serine,<br/>
165<br/>
methionine,&#160;and&#160;glycine<br/>
<i>rplN</i><br/>
&#160; &#160;E<br/>
Kasugamycin&#160;resistance<br/>
159<br/>
<i>rplN</i><br/>
&#160; &#160;E<br/>
Lincomycin&#160;resistance<br/>
343<br/>
<i>rplO</i><br/>
&#160; &#160;E<br/>
Lincomycin&#160;resistance<br/>
343<br/>
<i>rplV</i><br/>
&#160; &#160;E<br/>
Erythromycin&#160;resistance<br/>
840<br/>
<i>rpoA</i><br/>
&#160; &#160;E<br/>
P2&#160;<i>vir1</i>&#160;phage&#160;resistance<br/>
754<br/>
&#160; S<br/>
<i>rpoB</i><br/>
&#160; &#160;E<br/>
Lambda&#160;<i>c</i>II&#160;+&#160;rifampin&#160;coresistance<br/>
296<br/>
&#160; S<br/>
<i>rpoB</i><br/>
&#160; &#160;E<br/>
Streptovaricin&#160;resistance<br/>
863<br/>
&#160; S<br/>
<i>rpoB</i><br/>
&#160; &#160;E<br/>
Rifampin&#160;resistance<br/>
216,&#160;359,&#160;369<br/>
&#160; S<br/>
<i>rpoB</i><br/>
&#160; &#160;E<br/>
Streptolydigin&#160;resistance<br/>
357,&#160;469,&#160;688<br/>
&#160; S<br/>
<i>rpoB</i><br/>
&#160; &#160;S<br/>
Fluorouracil&#160;resistance<br/>
368<br/>
&#160; S<br/>
<i>rpoB</i><br/>
&#160; &#160;E<br/>
Lambda&#160;phage&#160;+&#160;434&#160;phage&#160;cross-resistance<br/>
256<br/>
&#160; S<br/>
<i>rpoB</i><br/>
&#160; &#160;E<br/>
Lambda&#160;<i>Nmar&#160;</i>mutant&#160;phage&#160;resistance<br/>
261<br/>
&#160; S<br/>
<i>rpoB</i><br/>
&#160; &#160;E<br/>
Serine&#160;resistance&#160;in&#160;<i>relA</i><br/>
784<br/>
&#160; S<br/>
<i>rpoB</i><br/>
&#160; &#160;E<br/>
Rifampin&#160;resistance&#160;in&#160;<i>rpoB</i>+/<i>rpoB</i>&#160;(<i>rif</i>)&#160;merodiploids<br/>
36<br/>
&#160; L<br/>
<i>rpoB</i><br/>
&#160; &#160;E<br/>
T7&#160;phage&#160;resistance<br/>
690<br/>
&#160; S<br/>
<i>rpoC</i><br/>
&#160; &#160;E<br/>
T7&#160;phage&#160;gene&#160;2&#160;resistance<br/>
100<br/>
<i>rpoD</i><br/>
&#160; &#160;E<br/>
Lambda&#160;<i>c</i>I71&#160;resistance<br/>
556<br/>
<i>rpoD</i><br/>
&#160; &#160;E<br/>
Arabinose&#160;(L)&#160;as&#160;C&#160;source&#160;in&#160;<i>cya</i>&#160;or&#160;<i>crp</i><br/>
712<br/>
&#160; S<br/>
<i>rpoH</i><br/>
&#160; &#160;E<br/>
Temperature&#160;resistance&#160;in&#160;<i>rpoD</i>(Ts)<br/>
577<br/>
&#160; S<br/>
<i>rpsB</i><br/>
&#160; &#160;E<br/>
Kasugamycin&#160;resistance<br/>
583,&#160;861<br/>
&#160; S<br/>
<hr/>
<a name=43></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>rpsB</i><br/>
&#160; &#160;E<br/>
Cold&#160;resistance&#160;in&#160;<i>rpsE</i>&#160;cold-sensitive&#160;mutants<br/>
559<br/>
<i>rpsC</i><br/>
&#160; &#160;E<br/>
Spectinomycin&#160;resistance&#160;and&#160;sucrose&#160;dependence<br/>
195<br/>
&#160; S<br/>
<i>rpsD</i><br/>
&#160; &#160;E<br/>
Spectinomycin&#160;resistance&#160;and&#160;sucrose&#160;dependence<br/>
195<br/>
&#160; S<br/>
<i>rpsD</i><br/>
&#160; &#160;E<br/>
Streptomycin&#160;independence&#160;of&#160;streptomycin-dependent<br/>
304<br/>
<i>rpsL</i><br/>
<i>rpsE</i><br/>
&#160; &#160;E<br/>
Spectinomycin&#160;resistance&#160;and&#160;sucrose&#160;dependence<br/>
195,&#160;526<br/>
&#160; S<br/>
<i>rpsE</i><br/>
&#160; &#160;E,&#160;S<br/>
Spectinomycin&#160;resistance<br/>
172,&#160;495,&#160;634,&#160;672,<br/>
&#160; S<br/>
853<br/>
<i>rpsE</i><br/>
&#160; &#160;E<br/>
Streptomycin&#160;independence&#160;of&#160;streptomycin-dependent<br/>
304<br/>
<i>rpsL</i><br/>
<i>rpsG</i><br/>
&#160; &#160;E<br/>
Lincomycin&#160;resistance<br/>
343<br/>
&#160; S<br/>
<i>rpsI</i><br/>
&#160; &#160;E<br/>
Kasugamycin&#160;resistance&#160;and&#160;dependence<br/>
161,&#160;163<br/>
&#160; S<br/>
<i>rpsJ</i><br/>
&#160; &#160;E<br/>
Lambda&#160;prophage&#160;induction,&#160;resistance&#160;to<br/>
170,&#160;246<br/>
&#160; S<br/>
<i>rpsL</i><br/>
&#160; &#160;E,&#160;S<br/>
Streptomycin&#160;resistance<br/>
89,&#160;495,&#160;853<br/>
&#160; S<br/>
<i>rpsL</i><br/>
&#160; &#160;E<br/>
Neamine&#160;dependence<br/>
798<br/>
<i>rpsL</i><br/>
&#160; &#160;E<br/>
Paromomycin&#160;resistance&#160;or&#160;dependence<br/>
853<br/>
&#160; S<br/>
<i>rpsL</i><br/>
&#160; &#160;E<br/>
Phenyl&#160;galactoside&#160;resistance&#160;of&#160;<i>lacP&#160;lacI</i>&#160;(nonsense)<br/>
747<br/>
<i>supE</i><br/>
<i>rpsM</i><br/>
&#160; &#160;E<br/>
Kasugamycin&#160;resistance<br/>
159<br/>
<i>rpsQ</i><br/>
&#160; &#160;E<br/>
Neamine&#160;resistance<br/>
76,&#160;119<br/>
&#160; S<br/>
<i>rpsR</i><br/>
&#160; &#160;E<br/>
Kasugamycin&#160;resistance<br/>
159<br/>
<i>rrn</i><br/>
&#160; &#160;E<br/>
Erythromycin&#160;resistance<br/>
704<br/>
&#160; S<br/>
<i>rrn</i><br/>
&#160; &#160;E<br/>
Chloramphenicol&#160;resistance<br/>
704<br/>
&#160; S<br/>
<i>rrn</i><br/>
&#160; &#160;E<br/>
Spectinomycin&#160;resistance<br/>
704<br/>
&#160; S<br/>
<i>sbaA</i><br/>
&#160; &#160;E<br/>
Serine&#160;resistance<br/>
166<br/>
<i>sbmA</i><br/>
&#160; &#160;E<br/>
Microcin&#160;B17&#160;resistance<br/>
446<br/>
<i>sdh</i><br/>
&#160; &#160;E<br/>
Succinate-independent&#160;growth&#160;in&#160;<i>lpd</i><br/>
154<br/>
<i>secA</i><br/>
&#160; &#160;E,&#160;S<br/>
Azide&#160;resistance<br/>
227,&#160;232,&#160;584,&#160;808,<br/>864<br/>
<i>secA</i><br/>
&#160; &#160;E<br/>
Phenethyl&#160;alcohol&#160;resistance<br/>
808,&#160;864<br/>
<i>semA</i><br/>
&#160; &#160;E<br/>
Microcin&#160;E492&#160;resistance<br/>
622<br/>
<i>serA</i><br/>
&#160; &#160;E<br/>
Serine&#160;hydroxamate&#160;resistance<br/>
774<br/>
&#160; FBI,&#160;S<br/>
<i>serS</i><br/>
&#160; &#160;E<br/>
Serine&#160;hydroxamate&#160;resistance<br/>
774<br/>
&#160; S<br/>
<i>sidCF</i><br/>
&#160; &#160;S<br/>
Albomycin&#160;resistance<br/>
87,&#160;478,&#160;479,&#160;674<br/>
<i>sidK</i><br/>
&#160; &#160;S<br/>
Albomycin&#160;resistance<br/>
87,&#160;478,&#160;479,&#160;674<br/>
<i>sidK</i><br/>
&#160; &#160;S<br/>
ES18&#160;phage&#160;resistance<br/>
87,&#160;478,&#160;479,&#160;674<br/>
<i>sloB</i><br/>
&#160; &#160;E<br/>
Nalidixic&#160;acid&#160;tolerance<br/>
473<br/>
<i>sloB</i><br/>
&#160; &#160;E<br/>
Amidinopenicillin&#160;tolerance<br/>
473<br/>
<i>sorAT</i><br/>
&#160; &#160;E<br/>
Sorbose&#160;(L)&#160;as&#160;C&#160;source&#160;in&#160;crosses&#160;with&#160;wild&#160;strains<br/>
844<br/>
<i>spcB</i><br/>
&#160; &#160;S<br/>
Spectinomycin&#160;resistance<br/>
853<br/>
<i>srlA</i><br/>
&#160; &#160;E<br/>
Sorbitol&#160;+&#160;xylitol&#160;resistance<br/>
639<br/>
&#160; L<br/>
<i>srlD</i><br/>
&#160; &#160;E<br/>
Fructose&#160;as&#160;C&#160;source&#160;in&#160;<i>ptsF</i>&#160;or&#160;<i>ptsM</i><br/>
378<br/>
<i>sspA</i><br/>
&#160; &#160;E<br/>
P1&#160;phage&#160;resistance<br/>
835<br/>
&#160; L<br/>
<i>strB</i><br/>
&#160; &#160;S<br/>
Streptomycin&#160;resistance<br/>
273,&#160;853<br/>
<i>strC</i><br/>
&#160; &#160;S<br/>
Streptomycin&#160;resistance<br/>
648<br/>
<i>strM</i><br/>
&#160; &#160;E<br/>
Streptomycin&#160;resistance<br/>
671<br/>
<i>strM</i><br/>
&#160; &#160;E<br/>
Phenyl&#160;galactoside&#160;resistance&#160;of&#160;<i>lacI</i>q&#160;<i>lacI</i>(nonsense)<br/>
748<br/>
<i>lacP&#160;supL</i><br/>
<i>sulA</i><br/>
&#160; &#160;E<br/>
UV&#160;irradiation&#160;resistance&#160;in&#160;<i>lon</i><br/>
373<br/>
&#160; L<br/>
<i>sulA</i><br/>
&#160; &#160;E<br/>
Methyl&#160;methanesulfonate&#160;resistance&#160;in&#160;<i>lon</i><br/>
373<br/>
&#160; L<br/>
<i>sulA</i><br/>
&#160; &#160;E<br/>
Nitrofurantoin&#160;resistance&#160;in&#160;<i>lon</i><br/>
252<br/>
&#160; L<br/>
<i>tabC</i><br/>
&#160; &#160;E<br/>
T4&#160;phage&#160;resistance<br/>
258<br/>
<i>tct</i><br/>
&#160; &#160;S<br/>
Fluorocitrate&#160;resistance<br/>
724<br/>
&#160; L<br/>
<i>tct</i><br/>
&#160; &#160;S<br/>
Trifluorocitrate&#160;resistance<br/>
723<br/>
&#160; L<br/>
<i>tct</i><br/>
&#160; &#160;S<br/>
2-Fluoro-L-erythrocitrate&#160;resistance<br/>
32<br/>
&#160; L<br/>
<i>tdk</i><br/>
&#160; &#160;E,&#160;S<br/>
Azidothymidine&#160;resistance<br/>
207<br/>
&#160; L<br/>
<hr/>
<a name=44></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>tdk</i><br/>
&#160; &#160;S<br/>
Fluorodeoxyuridine&#160;+&#160;uracil&#160;resistance&#160;in&#160;<i>deoA</i><br/>
54<br/>
<i>tdk</i><br/>
&#160; &#160;E<br/>
Fluoro(5)deoxyuridine&#160;resistance<br/>
749<br/>
&#160; L<br/>
<i>tdk</i><br/>
&#160; &#160;E<br/>
Bromo(5)deoxyuridine&#160;+&#160;UV&#160;irradiation&#160;resistance<br/>
319,&#160;348<br/>
&#160; L<br/>
“<i>tet</i>”<br/>
&#160; &#160;E,&#160;S<br/>
Fusaric&#160;acid&#160;resistance<br/>
72,&#160;487<br/>
&#160; L<br/>
“<i>tet</i>”<br/>
&#160; &#160;S<br/>
Quinaldic&#160;acid&#160;resistance<br/>
72<br/>
&#160; L<br/>
<i>thdA</i><br/>
&#160; &#160;E<br/>
Dapsone&#160;resistance<br/>
383<br/>
<i>thi</i><br/>
&#160; &#160;E<br/>
Pyrithiamine&#160;resistance<br/>
399<br/>
&#160; C<br/>
<i>thrA</i><br/>
&#160; &#160;E,&#160;S<br/>
Thialysine&#160;resistance<br/>
365<br/>
&#160; S,&#160;FBI<br/>
<i>thrA</i><br/>
&#160; &#160;E<br/>
Serine&#160;resistance<br/>
294<br/>
&#160; S,&#160;FBI<br/>
<i>thrABC</i><br/>
&#160; &#160;E<br/>
Amino(2)-hydroxy(3)-pentoate&#160;resistance<br/>
847<br/>
&#160; D<br/>
<i>thrS</i><br/>
&#160; &#160;E<br/>
Borrelidin&#160;resistance<br/>
248,&#160;276,&#160;560,&#160;596<br/>
&#160; S,&#160;Q<br/>
<i>thyA</i><br/>
&#160; &#160;E,&#160;S<br/>
Aminopterin&#160;resistance<br/>
66,&#160;123,&#160;325,&#160;730<br/>
&#160; L<br/>
<i>thyA</i><br/>
&#160; &#160;E<br/>
Trimethoprim&#160;resistance<br/>
66,&#160;730<br/>
&#160; L<br/>
<i>tinA</i>&#160;(<i>tlr</i>)<br/>
&#160; &#160;E,&#160;S<br/>
Thiolutin&#160;resistance<br/>
381,&#160;382,&#160;714<br/>
<i>tmk</i><br/>
&#160; &#160;E<br/>
Dideoxy(2′,3′)thymidine&#160;resistance<br/>
176<br/>
&#160; S<br/>
<i>tnaA</i><br/>
&#160; &#160;E<br/>
Tryptophan-supported&#160;growth&#160;at&#160;13°C<br/>
568<br/>
&#160; C<br/>
<i>tna</i><br/>
&#160; &#160;E<br/>
Indole&#160;+&#160;methyl(5)tryptophan-supported,&#160;glucose-<br/>
862<br/>
resistant&#160;growth&#160;in&#160;∆<i>trp</i><br/>
<i>tol</i><br/>
&#160; &#160;E<br/>
Bacteriocin&#160;tolerance<br/>
85,&#160;120,&#160;173,&#160;236<br/>
<i>tolQAB</i><br/>
&#160; &#160;E<br/>
Colicin&#160;E1&#160;resistance<br/>
449<br/>
<i>tolQAB</i><br/>
&#160; &#160;E<br/>
TuIa&#160;phage&#160;resistance<br/>
449<br/>
<i>tolB</i><br/>
&#160; &#160;E<br/>
Colicin&#160;E&#160;resistance<br/>
19<br/>
&#160; L<br/>
<i>tolB</i><br/>
&#160; &#160;E<br/>
Azaleucine&#160;resistance<br/>
19<br/>
&#160; L<br/>
<i>tolC</i><br/>
&#160; &#160;E<br/>
Colicin&#160;E1&#160;tolerance<br/>
536,&#160;653<br/>
&#160; L<br/>
<i>tolD</i><br/>
&#160; &#160;E<br/>
Colicin&#160;E2&#160;and&#160;E3&#160;tolerance<br/>
210<br/>
<i>tolD</i><br/>
&#160; &#160;E<br/>
Ampicillin&#160;resistance<br/>
105,&#160;210<br/>
<i>tolE</i><br/>
&#160; &#160;E<br/>
Colicin&#160;E2&#160;and&#160;E3&#160;tolerance<br/>
210,&#160;211<br/>
<i>tolE</i><br/>
&#160; &#160;E<br/>
Ampicillin&#160;resistance<br/>
210,&#160;211<br/>
<i>tolI</i><br/>
&#160; &#160;E<br/>
Colicin&#160;Ia&#160;and&#160;Ib&#160;tolerance<br/>
120<br/>
<i>tolJ</i><br/>
&#160; &#160;E<br/>
Colicin&#160;L,&#160;A,&#160;and&#160;S4&#160;tolerance<br/>
173<br/>
<i>tolM</i><br/>
&#160; &#160;E<br/>
Colicin&#160;M&#160;tolerance<br/>
302<br/>
<i>tolQ</i><br/>
&#160; &#160;E<br/>
Colicin&#160;group&#160;A&#160;tolerance<br/>
84a,&#160;750<br/>
<i>tolQ</i><br/>
&#160; &#160;E<br/>
Filamentous&#160;phage&#160;tolerance<br/>
84a,&#160;750<br/>
<i>tolR</i><br/>
&#160; &#160;E<br/>
Colicin&#160;group&#160;A&#160;tolerance<br/>
84a,&#160;750<br/>
<i>tolR</i><br/>
&#160; &#160;E<br/>
Filamentous&#160;phage&#160;tolerance<br/>
84a,&#160;750,&#160;751<br/>
<i>tolZ</i><br/>
&#160; &#160;E<br/>
Colicin&#160;E2,&#160;E3,&#160;D,&#160;1a,&#160;and&#160;1b&#160;tolerance<br/>
503<br/>
<i>tonB</i><br/>
&#160; &#160;S<br/>
ES18&#160;phage&#160;resistance<br/>
149,&#160;741<br/>
<i>tonB</i><br/>
&#160; &#160;E<br/>
T1&#160;phage&#160;resistance<br/>
46<br/>
<i>tonB</i><br/>
&#160; &#160;E<br/>
φ80&#160;phage&#160;resistance<br/>
46<br/>
<i>tonB</i><br/>
&#160; &#160;E<br/>
Colicin&#160;B&#160;resistance<br/>
46,&#160;623<br/>
<i>tonB</i><br/>
&#160; &#160;E,&#160;S<br/>
Albomycin&#160;resistance<br/>
85,&#160;505,&#160;741<br/>
<i>tonB</i><br/>
&#160; &#160;E<br/>
Colicin&#160;M&#160;resistance<br/>
85,&#160;523<br/>
<i>tonB</i><br/>
&#160; &#160;S<br/>
Bacteriocin&#160;4-59&#160;resistance<br/>
741<br/>
<i>tonB</i><br/>
&#160; &#160;E<br/>
Cephalosporin&#160;E-0702&#160;resistance<br/>
815<br/>
<i>topA</i><br/>
&#160; &#160;S<br/>
Kanamycin&#160;resistance<br/>
202<br/>
<i>topA</i><br/>
&#160; &#160;S<br/>
Neomycin&#160;resistance<br/>
202<br/>
<i>topA</i><br/>
&#160; &#160;S<br/>
Streptomycin&#160;resistance<br/>
202<br/>
<i>tpp</i><br/>
&#160; &#160;E<br/>
Alafosfalin&#160;resistance<br/>
603<br/>
&#160; L<br/>
<i>tpp</i><br/>
&#160; &#160;E<br/>
Triornithine&#160;resistance&#160;in&#160;<i>opp</i><br/>
44<br/>
&#160; L<br/>
<i>tppA</i><br/>
&#160; &#160;S<br/>
Tripeptide&#160;(toxic)&#160;resistance<br/>
263<br/>
<i>tppB</i><br/>
&#160; &#160;S<br/>
Tripeptide&#160;(toxic)&#160;resistance<br/>
263<br/>
<i>trmE</i>?<br/>
&#160; &#160;E<br/>
Phenyl&#160;galactoside&#160;resistance&#160;of&#160;<i>lacl</i>q&#160;<i>lacI</i>(nonsense)<br/>
748<br/>
<i>lacP&#160;supL</i><br/>
<i>trp</i>&#160;(generic)<br/>
&#160; &#160;E,&#160;S<br/>
Fluoro(6)tryptophan&#160;resistance<br/>
42,&#160;318<br/>
&#160; C<br/>
<hr/>
<a name=45></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>trp</i>&#160;(generic)<br/>
&#160; &#160;E,&#160;S<br/>
Methyl(5)tryptophan&#160;resistance<br/>
42,&#160;318<br/>
&#160; C<br/>
<i>trpE</i><br/>
&#160; &#160;E,&#160;S<br/>
Methyl(5)tryptophan&#160;resistance<br/>
114,&#160;539<br/>
&#160; S,&#160;FBI<br/>
<i>trpE</i><br/>
&#160; &#160;E<br/>
Methyl(3)anthranilate&#160;resistance<br/>
308<br/>
&#160; S,&#160;FBI<br/>
<i>trpR</i><br/>
&#160; &#160;E,&#160;S<br/>
Methyl(5)tryptophan&#160;resistance<br/>
42,&#160;137,&#160;523,&#160;746<br/>
<i>trpR</i><br/>
&#160; &#160;E<br/>
Chuangxinmycin&#160;resistance<br/>
850<br/>
<i>trpS</i><br/>
&#160; &#160;E<br/>
Indolmycin&#160;resistance<br/>
75<br/>
&#160; D<br/>
<i>trxA</i><br/>
&#160; &#160;E<br/>
T7&#160;phage&#160;resistance<br/>
498<br/>
&#160; L<br/>
<i>trzA</i><br/>
&#160; &#160;S<br/>
Triazole&#160;resistance<br/>
339<br/>
<i>tsx</i><br/>
&#160; &#160;E<br/>
T6&#160;phage&#160;resistance<br/>
99,&#160;299,&#160;490,&#160;492,<br/>
&#160; L,&#160;S<br/>
620<br/>
<i>tsx</i><br/>
&#160; &#160;E<br/>
Colicin&#160;K&#160;resistance<br/>
99,&#160;299,&#160;490,&#160;492,<br/>
&#160; L,&#160;S<br/>
620<br/>
<i>tsx</i><br/>
&#160; &#160;E<br/>
Albicidin&#160;resistance<br/>
69<br/>
<i>tufAB</i><br/>
&#160; &#160;E<br/>
Kirromycin&#160;resistance<br/>
220,&#160;356,&#160;763,&#160;795<br/>
<i>tufAB</i><br/>
&#160; &#160;E,&#160;S<br/>
Mocimycin&#160;resistance<br/>
335,&#160;794<br/>
<i>tyn</i><br/>
&#160; &#160;S<br/>
Tyramine&#160;as&#160;N&#160;source<br/>
549<br/>
<i>tyrA</i><br/>
&#160; &#160;E,&#160;S<br/>
Fluorophenylalanine&#160;resistance<br/>
270,&#160;729<br/>
&#160; C<br/>
<i>tyrA</i><br/>
&#160; &#160;E<br/>
Amino(4)phenylalanine&#160;resistance<br/>
504<br/>
&#160; C<br/>
<i>tyrR</i><br/>
&#160; &#160;E,&#160;S<br/>
Amino(4)phenylalanine&#160;resistance<br/>
95,&#160;504,&#160;811<br/>
<i>tyrR</i><br/>
&#160; &#160;E<br/>
Fluorotyrosine&#160;resistance<br/>
130<br/>
<i>tyrR</i><br/>
&#160; &#160;S<br/>
Fluoro(4)phenylalanine&#160;resistance<br/>
729<br/>
<i>tyrS</i><br/>
&#160; &#160;E<br/>
Fluorotyrosine&#160;resistance<br/>
662<br/>
&#160; S<br/>
<i>ubi</i>&#160;(generic)<br/>
&#160; &#160;E<br/>
Neomycin&#160;resistance<br/>
265<br/>
&#160; L<br/>
<i>ubiF</i><br/>
&#160; &#160;S<br/>
Fluoro(5)uracil&#160;+&#160;carbamylaspartate&#160;resistance<br/>
404,&#160;866<br/>
&#160; L<br/>
<i>ubiF</i><br/>
&#160; &#160;E<br/>
Gentamicin&#160;resistance<br/>
542<br/>
<i>ubiF</i><br/>
&#160; &#160;E<br/>
Streptomycin&#160;resistance<br/>
542<br/>
<i>udhA</i><br/>
&#160; &#160;S<br/>
Fluoro(5)uridine&#160;resistance<br/>
834<br/>
&#160; L<br/>
<i>udk</i><br/>
&#160; &#160;E<br/>
Fluoro(5)uridine&#160;+&#160;uracil&#160;resistance<br/>
380<br/>
&#160; L<br/>
<i>udk</i><br/>
&#160; &#160;E<br/>
Fluoro(5)uridine&#160;resistance&#160;in&#160;<i>upp</i><br/>
565<br/>
&#160; L<br/>
<i>udp</i><br/>
&#160; &#160;E<br/>
Fluoro(5)uracil&#160;+&#160;adenosine&#160;resistance<br/>
606,&#160;617<br/>
&#160; L<br/>
<i>ugpAB</i><br/>
&#160; &#160;E<br/>
Fluorohydroxyacetone&#160;phosphate&#160;resistance<br/>
515<br/>
&#160; L<br/>
<i>ugpAB</i><br/>
&#160; &#160;E<br/>
Dihydroxybutylphosphonate&#160;resistance&#160;in&#160;<i>glpT</i><br/>
691,&#160;692<br/>
&#160; L<br/>
<i>ugpAB</i><br/>
&#160; &#160;E<br/>
Glycerol-3-phosphate&#160;as&#160;C&#160;source&#160;in&#160;<i>glpT</i><br/>
691<br/>
&#160; C<br/>
<i>uhpR</i><br/>
&#160; &#160;E<br/>
Glucosamine&#160;6-phosphate&#160;as&#160;C&#160;source<br/>
191<br/>
&#160; C<br/>
<i>uhpR</i><br/>
&#160; &#160;S<br/>
Glucose&#160;1-phosphate&#160;as&#160;C&#160;source<br/>
192<br/>
&#160; C<br/>
<i>uhpR</i><br/>
&#160; &#160;E<br/>
Fructose&#160;1-phosphate&#160;as&#160;C&#160;source<br/>
224<br/>
&#160; C<br/>
<i>uhpT</i><br/>
&#160; &#160;E<br/>
Chloro-3-hydroxyacetone&#160;resistance&#160;in&#160;<i>uhp</i>(Con)<br/>
515<br/>
&#160; L<br/>
<i>uhpT</i><br/>
&#160; &#160;E<br/>
Fluoro-3-hydroxyacetone&#160;resistance&#160;in&#160;<i>uhp</i>(Con)<br/>
515<br/>
&#160; L<br/>
<i>uhpT</i><br/>
&#160; &#160;E<br/>
Dihydroxybutylphosphonate&#160;resistance&#160;in&#160;<i>uhp</i>(Con)<br/>
285<br/>
&#160; L<br/>
<i>uhpT</i><br/>
&#160; &#160;E<br/>
Hydroxybutylphosphonate&#160;resistance&#160;in&#160;<i>ubp</i>(Con)<br/>
285<br/>
&#160; L<br/>
<i>uhpT</i><br/>
&#160; &#160;E<br/>
Deoxydihydroxyphosphonyl&#160;methyl&#160;fructose&#160;resistance<br/>
285<br/>
&#160; L<br/>
<i>uhpT</i><br/>
&#160; &#160;E<br/>
L-Glyceraldehyde-3-phosphate&#160;resistance&#160;in&#160;<i>uhp</i>(Con)<br/>
285<br/>
&#160; L<br/>
<i>uhpT</i><br/>
&#160; &#160;E<br/>
Fosfomycin&#160;resistance<br/>
230,&#160;389,&#160;800<br/>
&#160; L<br/>
<i>uhpT</i><br/>
&#160; &#160;E<br/>
Deoxy(2)glucose-6-phosphate&#160;resistance<br/>
214<br/>
&#160; L<br/>
<i>uidA</i><br/>
&#160; &#160;E<br/>
Galacturonide&#160;as&#160;C&#160;source<br/>
742<br/>
&#160; C<br/>
<i>uidA</i><br/>
&#160; &#160;E<br/>
Methylgalacturonide&#160;as&#160;C&#160;source<br/>
573<br/>
&#160; C<br/>
<i>uidA</i><br/>
&#160; &#160;E<br/>
Methylglucuronide&#160;+&#160;glycerol-supported&#160;growth&#160;in&#160;<i>eda</i><br/>
572<br/>
&#160; L<br/>
<i>uidR</i><br/>
&#160; &#160;E<br/>
Galacturonide&#160;as&#160;C&#160;source<br/>
742<br/>
&#160; C<br/>
<i>uidR</i><br/>
&#160; &#160;E<br/>
Methylgalacturonide&#160;as&#160;C&#160;source<br/>
573<br/>
&#160; C<br/>
<i>ung</i><br/>
&#160; &#160;E<br/>
Bromodeoxyuridine&#160;+&#160;UV&#160;light&#160;resistance<br/>
856<br/>
&#160; L<br/>
<i>ung</i><br/>
&#160; &#160;E<br/>
T4&#160;phage&#160;(uracil&#160;containing)&#160;resistance<br/>
203<br/>
&#160; L<br/>
<i>upp</i><br/>
&#160; &#160;E,&#160;S<br/>
Fluoro(5)uracil&#160;resistance<br/>
53,&#160;605,&#160;617<br/>
&#160; L<br/>
<i>upp</i><br/>
&#160; &#160;E<br/>
Aza(6)uracil&#160;resistance<br/>
605,&#160;617<br/>
&#160; L<br/>
<hr/>
<a name=46></a>Gene<br/>
Organism<i>a</i><br/>
Selection<i>b</i><br/>
Reference(s)<br/>
Alteration<i>c</i><br/>
<i>upp</i><br/>
&#160; &#160;E<br/>
Canavanine&#160;+&#160;aza(6)uracil&#160;resistance<br/>
605,&#160;617<br/>
&#160; L<br/>
<i>ushA</i><br/>
&#160; &#160;E<br/>
Fluoro(5)uracil&#160;+&#160;5′-AMP&#160;resistance&#160;in&#160;<i>upp</i><br/>
52<br/>
&#160; L<br/>
<i>uvrA</i><br/>
&#160; &#160;E<br/>
UV-irradiated&#160;lytic&#160;phage&#160;resistance<br/>
332<br/>
<i>uvrB</i><br/>
&#160; &#160;E<br/>
UV-irradiated&#160;lytic&#160;phage&#160;resistance<br/>
332<br/>
<i>uvrC</i><br/>
&#160; &#160;E<br/>
UV-irradiated&#160;lytic&#160;phage&#160;resistance<br/>
332<br/>
<i>uvrD</i><br/>
&#160; &#160;E<br/>
UV-irradiated&#160;lytic&#160;phage&#160;resistance<br/>
332<br/>
<i>uxaBC</i><br/>
&#160; &#160;E<br/>
Hexuronate&#160;resistance&#160;in&#160;<i>eda</i><br/>
742<br/>
&#160; L<br/>
<i>uxuAB</i><br/>
&#160; &#160;E<br/>
Hexuronate&#160;resistance&#160;in&#160;<i>eda</i><br/>
742<br/>
&#160; L<br/>
<i>uxuR</i><br/>
&#160; &#160;E<br/>
Methylgalacturonide&#160;as&#160;C&#160;source<br/>
574<br/>
&#160; C<br/>
<i>valS</i><br/>
&#160; &#160;E<br/>
Thymineless&#160;death&#160;resistance&#160;in&#160;<i>thyA</i><br/>
394<br/>
&#160; S<br/>
<i>xapA</i><br/>
&#160; &#160;E<br/>
Fluoro(5)uracil&#160;+&#160;adenosine&#160;resistance&#160;in&#160;<i>upp&#160;deoD</i><br/>
111<br/>
&#160; L<br/>
<i>xapR</i>(Con)<br/>
<i>xapR</i><br/>
&#160; &#160;E<br/>
Adenosine&#160;as&#160;C&#160;source&#160;in&#160;<i>upp&#160;deoD</i><br/>
111<br/>
&#160; C<br/>
<i>xapR</i><br/>
&#160; &#160;E<br/>
Inosine&#160;as&#160;C&#160;source&#160;in&#160;<i>upp&#160;deoD</i><br/>
111<br/>
&#160; C<br/>
<i>xylE</i><br/>
&#160; &#160;E<br/>
Xylose&#160;resistance&#160;in&#160;<i>fda</i><br/>
175<br/>
&#160; L<br/>
</body>
</html>

<i>a</i>E,&#160;<i>E.&#160;coli;</i>&#160;S,&#160;<i>S.&#160;typhimurium.<br/>b</i>Abbreviations:&#160;DCCD,&#160;<i>N,N&#160;</i>′-dicyclohexylcarbodiimide;&#160;CCCP,&#160;carbonyl&#160;cyanide&#160;<i>m</i>-chlorophenylhydrazone;&#160;cAMP,&#160;cyclic<br/>AMP;&#160;DAP,&#160;diaminopimelic&#160;acid;&#160;(Con),&#160;constitutive;&#160;(Ts),&#160;heat&#160;sensitive.<br/><i>c</i>S,&#160;structure;&#160;FBI,&#160;site&#160;of&#160;feedback&#160;inhibition;&#160;D,&#160;increased&#160;gene&#160;dosage;&#160;C,&#160;constitutive&#160;gene&#160;expression;&#160;Q,&#160;altered&#160;amount<br/>of&#160;gene&#160;product;&#160;G,&#160;gain&#160;of&#160;function;&#160;L,&#160;loss&#160;of&#160;function.<br/>
<i>d</i>L.&#160;Comai,&#160;U.S.&#160;Patent&#160;4,535,060,&#160;1988;&#160;L.&#160;Comai,&#160;European&#160;patent&#160;application&#160;389066,&#160;1984.<br/><i>e</i>N.&#160;S.&#160;C.&#160;Lin,&#160;D.&#160;T.&#160;Palmer,&#160;and&#160;H.&#160;I.&#160;Miller,&#160;European&#160;patent&#160;application&#160;EP&#160;85-308408&#160;and&#160;U.S.&#160;patent&#160;application&#160;84-<br/>673955,&#160;1986.<br/>
<i>f</i>E.&#160;S.&#160;Miller,&#160;thesis,&#160;Purdue&#160;University,&#160;West&#160;Lafayette,&#160;Ind.,&#160;1984.<br/><i>g</i>S.&#160;Epelbaum,&#160;Z.&#160;Barak,&#160;R.&#160;LaRossa,&#160;and&#160;D.&#160;Chipman,&#160;unpublished&#160;data.<br/>
<i>h</i>C.&#160;S.&#160;Freitag,&#160;Ph.D.&#160;thesis,&#160;North&#160;Carolina&#160;State&#160;University,&#160;Raleigh,&#160;1982.<br/>
<hr/>